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1 Introduction 
1.1 Entamoeba histolytica 
1.1.1 The parasite 
The microaerophilic protozoan parasite Entamoeba histolytica generates a 
severe public health problem in developing countries, being the causative agent of 
amoebic dysentery and amoebic liver abcess. According to WHO reports it causes 
several million cases of disease and up to 100,000 deaths per annum, as a parasite 
disease being second only to malaria (WHO report on amoebiasis, 1997). The first 
description of the species was given by the Russian Fedor Lösch in 1875 (Lösch, 
1875), who observed trophozoites in feces from a farmer with dysentery and named the 
parasite Amoeba coli.  Not until 1903 the still valid name of Entamoeba histolytica was 
established by Fritz Schaudinn (Schaudinn, 1903), indicating its ability of host tissue 
destruction.  
Although the disease is mainly found in warm and humid climates of the world, it 
has been observed in nearly every latitude (Brandt and Tamayo, 1970). Only in recent 
time infections are seen in countries where amoebiasis is not endemic, like Japan or 
Australia, where the parasite is transmitted via oral-anal sex among homosexual men 
(Stark et al., 2008). Often people with E. histolytica infections show no signs of disease 
and can clear the infection without any problems. However, 4-10% of these 
asymptomatic carriers develop disease over a year (Gathiram and Jackson, 1987). 
The life cycle of E. histolytica is simple compared to other protozoans, consisting 
only of the amoeboid trophozoite and the infectious cyst stage. Cysts are usually 
transmitted via the fecal-oral route by consumption of contaminated water or food. After 
ingestion, the tetranucleated cysts pass the stomach without taking harm by the acidic 
environment because of their chitin wall, and hatch in the terminal ileum or proximal 
colon thereby producing eight small daughter trophozoites. These colonise the colon. 
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They can ingest bacteria, reproduce by binary fission and invade the host tissue where 
they feed on red blood cells and consequently can cause amoebic colitis or even 
amoebic liver abscess (Martinez-Palomo, 1982). Alternatively, trophozoites can encyst 
and leave the colon with stool, closing the infectious cycle.  
     The two main manifestations of human amoebiasis are the intestinal form, the colitis, 
where typical flask-shaped ulcers are formed in the submucosal tissues due to lateral 
spread, leading to diarrhoea and sometimes also fever and weight loss, as well as the 
most frequent extraintestinal occurrence, the amoebic liver abcess (ALA), forming often 
large solitary lesions in the liver (Stanley, 2003) that cause fever, hepatic tenderness 
and abdominal pain. Much rarer forms affect the respiratory tract or the brain. It has 
long been observed that the main part of ALA formation occurs in men between the age 
of 18 and 50, although the reasons for this phenomenon are not yet understood in 
detail.  A recent study using a mouse model of disease showed that female mice had 
higher IFN-γ levels than male ones at the beginning of ALA formation (Lotter et al., 
2006). Additionally, the importance of natural killer T cells in the host defence against 
ALA development was demonstrated. 
 
1.1.2 Phylogeny 
The genus Entamoeba belongs to the phylum Entamoebidae.  It is described as 
distantly related to the genera Mastigamoeba and Dictyostelium, which together form 
the monophylum Conosa (Clark 2000, Bapteste et al., 2002). There are free-living 
amoebae like E. moshkovskii, gut commensals like E. coli as well as E. gingivalis, 
which causes oral infections. The reptilian parasite E. invadens is interesting for 
researchers because it is rather easy to induce encystation in axenic cultures of this 
species (Eichinger, 1997), whereas E. histolytica encystment until today has only been 
induced in monoxenic cultures of the parasite (Clark and Diamond, 2002). 
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Due to its apparent lack of cell organelles like mitochondria and Golgi apparatus, 
E. histolytica was long grouped with two other amitochondriate parasites, Giardia 
intestinalis and Trichomonas vaginalis, as phylum Archezoa, all of them also being 
microaerophilic. But already in 1995 the chaperonin 60 gene (cpn60) of E. histolytica 
was found to be homologous to the respective mitochondrial protein, what provided a 
first direct evidence for the secondary loss of mitochondria in Entamoeba (Clark and 
Roger, 1995). 
Many different species of amoebae have been isolated from different hosts and 
the environment. One simple method to group them was to look at the number of nuclei 
in the cyst.  New genetic methods use the analysis of the relationships between small 
subunit rRNA gene sequences (Clark et al., 2006a). Data obtained with this method 
suggest that tetranucleated cyst-producing species like E. histolytica are descended 
from uninucleated cyst-producers. E. gingivalis, which produces no cysts, appears to 
have secondarily lost this ability and may descend from a uninucleated cyst-producing 
species as well.  
At the beginning of Entamoeba research all amoebic organisms found in human 
patients were addressed as E. histolytica. But already in 1925 Émile Brumpt suggested 
that at least one other species must exist which morphologically looks virtually identical 
but causes no disease (Brumpt, 1925). Consequently, he proposed the name of E. 
dispar for this species with clearly distinct properties. But this work found no response 
until several decades later molecular biological data suggested that there is a separate 
nonpathogenic species. The isoenzyme patterns of phosphoglucomutase (Sargeaunt et 
al., 1978) as well as those of hexokinases I and II (Farri et al., 1980) formed one part of 
the evidence for two different species. Support on the genetic level came from 
restriction fragment length polymorphism found in cDNA clones of pathogenic and 
nonpathogenic isolates (Tannich and Burchard 1991). Finally, in a redescription, E. 
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histolytica was separated from E. dispar (Diamond and Clark, 1993). This separation 
was widely accepted and still more evidence was found, e.g. the molecular biological 
explanation of the isoenzyme patterns of hexokinases and phosphoglucomutase 
(Ortner et al., 1997a; 1997b). 
 
1.1.3 Cell biology 
Entamoeba histolytica cysts are round with 10-15µm in diameter, comprising four 
nuclei surrounded by a rigid chitin wall. In contrast, the mobile trophozoites can reach 
10-50µm in diameter (Stanley, 2003).  
The cell structure of E. histolytica for a long time was regarded as very simple for 
a eukaryote, lacking for instance mitochondria, a Golgi-apparatus (GA) and an 
endoplasmatic reticulum (ER). One explanation was that amoebae were living fossils 
which had never acquired prokaryotic endosymbionts (Cavalier-Smith, 1991; Poole and 
Penny, 2007). But already in 1973 the so-called “hydrogenosome” had been discovered 
in T. vaginalis, a double-membrane organelle producing molecular hydrogen (Lindmark 
and Müller, 1973). Hrdy et al. (2004) showed that the 51-kDa and 24-kDa subunits of 
the NADH dehydrogenase module in complex I, the first step in the mitochondrial 
respiratory chain, are present in T. vaginalis. According to phylogenetic analysis they 
share common ancestry with the mitochondrial homologs. These findings support the 
theory that mitochondria and hydrogenosomes are aerobic and anaerobic homologs of 
the same endosymbiontically derived organelle.  
Finally, in E. histolytica (Tovar et al., 1999; Mai et al., 1999) and in Giardia 
intestinalis (Tovar et al., 2003) the so called “mitosomes” were discovered, also termed 
“cryptons” in E. histolytica (Mai et al., 1999). These organelles are surrounded by a 
double membrane and are targeted by mitochondrial-related proteins, e.g. molecular 
chaperones Hsp10, Hsp60 and Hsp70 (Bakatselou et al., 2000; Tovar et al., 2007) and 
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an unusual ADP/ATP carrier (Chan et al., 2005). The function of mitosomes is still 
controversial, one hypothesis says that they play a role in iron-sulfur (Fe-S) protein 
maturation (Tovar et al., 2003; Maralikova et al., 2010) as well as that they contain a 
sulfate activation pathway, a function that in eukaryotes is generally localised in the 
cytoplasm and plastids (Mi-Ichi et al., 2009). These findings seem to support the theory 
that all eukaryotes, those with fully functional mitochondria as well as those with 
mitosomes and hydrogenosomes, are derived from one common ancestor (van der 
Giezen and Tovar, 2005; Richards and van der Giezen, 2006). 
For a long time, E. histolytica seemed also to be devoid of a Golgi-system and an 
endoplasmatic reticulum (ER). But then advanced methods in staining and microscopy 
suggested that some of the numerous vesicles in the trophozoites could correspond to 
components of the ER and Golgi-complex (Mazzuco et al., 1997). Later on, different 
studies showed that the parasite contains vesicles that can be addressed as ER and 
Golgi-apparatus with different antibodies or by exploring their capability of transporting 
typical substances into their lumen, e.g. UDP-glucose (Gosh et al., 1999, Bredeston et 
al., 2005). So seemingly the function of these cell compartments is present even if the 
appearence of the organelles is somewhat different. 
Entamoeba trophozoites contain proteasomes in their cytoplasm that seem to 
play an important role in cell differentiation and replication, as is shown by treatment of 
cells with proteasome inhibitors (Makioka et al., 2002). This fact makes them an 
interesting therapeutic target in E. histolytica, as well as in other pathogenic protozoan 
parasites (Paugam et al., 2003). 
Entamoeba histolytica trophozoites have a pronounced ability for amoeboid 
motion and phagocytosis. This ability is a key feature in the pathogenicity of this 
parasite and has therefore been studied extensively (Meza et al., 2006). Chemotaxis 
seems to play an important role in this matter (Zaki et al., 2006). E. histolytica 
 
- 6 -
trophozoites exhibit bipolarity, with the pseudopod at the front of the cell and the so-
called uroid at the rear side (Bailey et al., 1992). The amoeba cytoskeleton is actin-rich, 
and both of the mentioned structures are formed by redistribution of F-actin (Guillén, 
1996). Actin interacts with several other actin-binding proteins, such as the gelation 
factor ABP-120. It binds to E. histolytica F-actin and during movements of trophozoites 
localizes in the pseudopod and uroid region, suggesting a role for this protein in motility 
and the so-termed capping of surface receptors (Vargas et al., 1996). Capping at the 
surface of cells can be seen as a two-step process. First, receptors which have been 
exposed to ligands such as host antibodies and complement, are transferred to 
particular sites on the cell surface and form patches there. Then, these patches move 
rearwards to the uroid. Where they are concentrated a cap is formed which finally is 
eliminated with the uropodial structure itself (Arhets et al., 1995). 
 
1.1.4 The genome 
 E. histolytica chromosomes do not condense during mitosis, making the 
identification of the exact number of chromosomes and the ploidy very difficult. Pulsed 
field gel electrophoresis predicts 14 chromosomes ranging from 0.3 to 2.2 Mbp and a 
possible ploidy of 4 (Willhoeft and Tannich, 1999). However, a recent study showed that 
the coupling between nuclear division and cytokinesis is abrogated, resulting in a wide 
range of different ploidy (Muhkerjee et al., 2009). The E. histolytica genome project was 
carried out at the Institute for Genomic Research (TIGR) in Rockville, Maryland, and at 
the Wellcome Trust Sanger Institute in Cambridge. It was built on a whole Entamoeba 
community effort to establish a basis for future research, for instance we provided our 
annotation databases (see 3.1 our publication on databases and 4.1 Conclusions). The 
draft genome sequence was published in 2005 (Loftus et al., 2005). The pathogenic 
strain HM-1:IMSS was sequenced by the whole-genome shotgun method. The 
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assembly is based on a 12.5-fold coverage of the genome. 9,938 genes were predicted 
to be contained in 23,751,783 base pairs (bp) distributed on 888 scaffolds. Genes have 
an average size of 1.17 kilobases (kb) and contain 49% of the genome sequence. Up to 
25% of the forecast genes were predicted to contain introns, with 6% perhaps even 
containing multiple introns. A striking feature of the E. histolytica genome is the huge 
amount of tRNA-encoding arrays (Clark et al., 2006b). They make up around 10% of 
the whole genome and are mostly organized in linear arrays, 25 types of these have 
been identified, each containing up to five tRNA types per repeat unit. Several 
properties of the arrays suggest that they are located in subtelomeric regions and also 
fulfil a structural role, as has been proposed for the rDNA of Dictyostelium discoideum 
(Eichinger et al., 2005).  The unusual organisation of rRNA-encoding genes is another 
trait of the parasite´s genome. They are located on extrachromosomal plasmids which 
can be found in around 200 copies per cell (Bhattacharya et al., 1998) and make up 
about 20% of the total DNA amount per cell.  
 Interestingly, the genome of E. histolytica contains a considerable amount of 
genes of assumed bacterial origin. Several important metabolic enzymes have been 
replaced by prokaryotic types. Examples that have been known for some time are 
fructose-1,6-bisphosphate aldolase (Sánchez et al., 2002), malic enzyme, acetyl-CoA 
synthetase (Field et al., 2000), aldehyde-alcohol dehydrogenase (ADH2) (Bruchhaus 
and Tannich, 1994) and the genes thought to be involved in metronidazole activation 
(see below), pyruvate:ferredoxin oxidoreductase (PFOR) and ferredoxin (FD) 
(Rosenthal et al., 1997).  There are three different possible explanations for the 
presence of bacterial genes in eukaryotes. The amitochondriate fossil hypothesis says 
that these genes could be derived from an ancient anaerobe eukaryote without 
mitochondria. The hydrogen hypothesis suggests that fermentation enzymes were 
gained with the mitochondrial endosymbiont, and the lateral gene transfer (LGT) 
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hypothesis means that there was direct transfer of genes from prokaryotes to 
eukaryotes. Many publications find support for LGT (e.g. Alsmark et al., 2009; 
Andersson et al., 2003; Nixon et al., 2002).  
 Transposable elements make up a significant part of the E. histolytica genome. 
There are three subtypes of LINEs (long interspersed  elements) EhLINE1, 2 and 3 as 
well as three subtypes of SINEs (short interspersed elements) EhSINE 1, 2 and 3, 
ranging in copy number from only a few to far over 100 (Bakre et al., 2005).  
 The publication of the E. histolytica draft genome sequence immensely 
enhanced research on this organism, making possible new approaches of study, e.g. 
gene expression analysis with microarrays or the analysis of the whole proteome of the 
parasite. 
 
1.1.5 Metabolism 
Life as a microaerophilic parasite strongly shaped the metabolism of Entamoeba 
histolytica. This environment rules out oxidative phosphorylation. As no tricarboxylic 
acid (TCA) cycle is found either, amoebae rely on substrate level phosphorylation 
(Reeves, 1984).  Glycolysis appears to take place in the cytosol like in higher 
eukaryotes but different from trypanosomes where the first activating steps of glycolysis 
occur in the so-called glycosomes, maybe to prevent a toxic accumulation of 
intermediates (Haanstra et al., 2008). For a long time, Entamoeba was thought to lack 
any compartmentalised energy production and therefore was grouped as type I 
amitochondrate protist, contrary to T. vaginalis which contains hydrogenosomes and 
therefore was classified as type II amitochondriate protist (Martin and Müller, 1998).  
The main part of ATP is generated through glycolysis, but the genome project 
found several genes, sometimes with bacterial background, that could contribute to 
ATP production by amino acid catabolism, e.g. aminotransferases (Clark et al., 2007; 
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Anderson and Loftus, 2005). Typically, after a first transamination step a 2-ketoacid is 
generated, that could be pyruvate or some other 2-ketoacid. This can be used with the 
help of PFOR (see below) to generate CoA-thioesters from which one ATP per 
molecule can be produced.  
Amoebae live in the human gut, hence they have easy access to many 
preformed bacterial and host-derived organic compounds such as lipids or cholesterol 
(Das et al., 2002). It was noted very early that amoebae and other protozoan parasites 
can take up these compounds from the host and, in addition, that especially cholesterol 
has an influence on the virulence of parasites, also in E. histolytica (e.g. Ormerod and 
Venkatesan, 1982; Sharma, 1959). So it is an interesting question if amoebae still have 
genes of the cholesterol synthesis pathway in their genome. Furthermore, there are 
hints that amoebae and other amitochondriate protozoa like Giardia and Trichomonas 
are able to alter host-derived lipids or are capable of elongating/desaturating fatty acids. 
While compiling the annotation database for our project we searched the genome for 
genes coding for the enzymes of these pathways (see 4.1 Conclusions).  
The enzyme pyruvate:ferredoxin oxidoreductase (PFOR) is of immense 
significance to Entamoeba, as the parasite lacks a pyruvate dehydrogenase or pyruvate 
decarboxylase. This bacterial-type iron-sulfur enzyme oxidatively decarboxylates 
pyruvate to acetyl-CoA. Electrons are transferred to ferredoxin which then reduces 
further substrates. In addition, it can probably activate metronidazole, the main 
antiamoebic drug (Müller, 1986) (see below, point 1.2). 
 
1.1.6 Pathophysiology 
Amoebic colitis can result in mucosal thickening to discrete ulcer formation up to 
necrosis and intestinal wall perforation (Stanley, 2003). The process always starts with 
adherence of the E. histolytica trophozoites to the colonic mucus and epithelium 
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(Bansal et al., 2009) mediated through the galactoase/N-acetylgalactosamine specific 
(Gal/GalNAc) lectin, a major pathogenic factor of amoebae comprising disulphide-linked 
170 kDa and 35/31 kDa subunits (Mann, 2002). In some hamster cell lines that lack N-
terminal galactose or N-acetylgalactosamine residues on their surface, a direct contact 
of amoebae with the cells is impossible and no cell killing can occur (Li et al., 1988). 
After adhesion of the amoebae, cytolysis is mediated by the amoebapores, small 
proteins that are highly effective in lysing lipid bilayers (Leippe, 1997). The attacked 
host cells undergo apoptosis (Huston et al., 2000 and 2003), as shown by the activation 
of caspase 3 in engulfed Jurkat T cells, contact via the amoeba Gal/GalNAc lectin being 
necessary.  
The third major group of pathogenicity factors in E. histolytica are the cysteine 
proteinases. These enzymes which are found in all organisms play an important role in 
tissue invasion, e.g. they were shown to disturb enteric microvilli and thereby mediate 
an intimate contact between the amoebae and enteric cells (Lauwaet  et al., 2003). 
After tissue invasion the amoebae enter the host blood stream and there encounter the 
complement system and host antibodies. These can be cleaved by excreted cysteine 
proteinases (Reed et al., 1989; Kelsall and Ravdin, 1993). Interestingly, the strict 
commensal Entamoeba dispar does not express the cysteine proteinase CP5. The 
gene encoding CP5 is present, but highly degenerated and therefore not expressed 
(Willhoeft et al., 1999). Most of the other pathogenicity factors are present in E. dispar 
but are only weakly expressed, e.g. one study showed differences in the structure and 
activity of pore forming peptides in E. dispar (Nickel et al., 1999). These discrepancies 
could to some extent explain the differences in pathogenicity of the two closely related 
species, but more recent studies show that many more factors seem to be involved in 
Entamoeba pathogenicity, for instance protection against oxidative stress by 
peroxiredoxin (Lejeune et al., 2009; Biller et al., 2009). Moreover, pathogenicity also 
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depends on the host response during the development of the disease (Lotter et al., 
2009). 
When trophozoites finally reach the liver, probably via the portal circulation, they 
cause typical abscesses consisting of areas of dead hepatocytes, liquefied cells and 
cellular debris (Stanley, 2003). The often surprisingly small number of amoebae relative 
to the size of the abscess could hint to an abilitiy to elicit apoptosis in hepatocytes 
without direct contact.  
 
1.1.7 Diagnosis 
For many years the microscopic analysis of stool samples has been nearly the 
only method to diagnose an Entamoeba infection in patients with diarrhoea. However, 
only well-trained personnel can readily distinguish the Entamoeba trophozoites from 
leukocytes and from other intestinal protozoa (Stanley, 2003). Furthermore, even after 
the firm establishment of the two distinct species E. histolytica and E. dispar, it was not 
possible to differentiate between the two by microscopy due to their morphological 
similarity, leading to unnecessary treatment of people only harbouring E. dispar. 
Meanwhile, several more sophisticated methods for diagnosis and differentiation were 
developed, such as enzyme-linked immunosorbent assays (ELISAs), PCR and real-
time PCR. Of these techniques, only ELISAs are widely used in endemic areas 
because they are not so costly and easy to perform, one example is the TechLab E. 
histolytica II test that was reported to be sensitive and specific (Buss et al., 2008). PCR 
and real-time PCR are very sensitive methods that can be also used to diagnose 
amoebic liver abscess and to detect several different pathogens at once in a sample 
(Singh et al., 2009; Roy et al., 2005). These methods will become more important in the 
future, e.g. for epidemiological studies. Meanwhile serology, looking for anti-Entamoeba 
antibodies, plays a large role in diagnosing invasive disease together with stool 
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examination. For detecting liver abscesses, serology and ultrasound scanning of the 
liver are the widely used methods.  
 
1.1.8 Prevention 
Of course great efforts have been undertaken in the last decades to provide a 
vaccine against amoebic diseases (Lotter and Tannich, 2006). Several possible 
antigens have been recognized, e.g. the Gal/GalNac lectin (Petri et al., 2006) or 
passive protection by an antibody against lipophosphoglycans (LPG) (Marinets et al., 
1997). Nevertheless, none of these candidate vaccines have yet reached clinical 
studies, so the actual availability of a vaccine is still many years away. What´s more, 
providing better sanitary conditions, clean water and clean food in developing countries 
would minimalise the risk for acquiring amoebiasis dramatically and also improve the 
life of the affected people in many more ways than finding a vaccine against one of 
many possible causes of disease. Unfortunately, this goal seems even further away 
than developing an amoebiasis vaccine.  
 
 
1.2 Treatment of parasitic diseases, the role of the nitroimidazoles 
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For several decades, the 5-nitroimidazoles with their best known proponents 
metronidazole, ornidazole and tinidazole have been the cornerstone of antiamoebic 
treatment. These chemotherapeutical agents are generally administered against 
anaerobe parasites and bacteria, such as Trichomonas vaginalis, Gardia lamblia or 
Bacteroides fragilis (Ali and Nozaki, 2007; Fung and Doan, 2005). In the management 
of amoebic colitis, the three mentioned drugs are nearly equally effective, perhaps with 
a slight advantage for tinidazole and ornidazole, but in some countries, e.g. the USA, 
only metronidazole is available (Stanley, 2003). Normal treatment consists of the 
administration of 750 mg of metronidazole three times a day for 5-10 days. 
Subsequently, an additional treatment with the luminal agents paromomycin, iodoquinol 
or diloxanide furoate is strictly recommended for eradication of amoeba colonisation, as 
nitroimidazoles are not as effective against luminal amoebae.  
The treatment of amoebic liver abscess in most cases is comparable to that of 
amoebic colitis, as even large abscesses can be cured by the administration of 
metronidazole alone. The additional use of surgical drainage in uncomplicated ALA is 
controversial, with authors advising against it (Akgun et al.,1999) and others wanting for 
more randomised trials to decide this matter as those available now do not possess the 
necessary quality (Chavez-Tapia et al., 2009). Comparable to amoebic colitis, 
metronidazole treatment must be followed by administration of a luminal agent to 
eradicate intestinal colonisation. 
One drug that could become important in the future of amoebiasis treatment is 
nitazoxanide, a broad-spectrum antiparasitic drug with activity also against Giardia and 
Trichomonas as well as helminths (Rossignol et al., 2001). Another interesting group of 
substances are the alkylphosphocholines (alkyl-PC), originally developed as anti-cancer 
drugs, which were found to posses a strong antiamoebic activity (Seifert et al., 2001). 
Miltefosine, one of the alkyl-PCs, is already in use against visceral leishmaniasis 
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(caused by Leishmania donovani) in India, but alkyl-PCs are also effective against 
Trypanosoma spp. (Croft et al., 2003) and Acanthamoeba spp. (Walochnik et al., 2002).  
Resistance to metronidazole is a problem of variable importance in the 
“amitochondriate” parasites E. histolytica, G. intestinalis and T. vaginalis. In 
Entamoeba, no clinical isolates with a high level of resistance are observed until now, 
although exposure to nonlethal drug levels could increase drug resistance (Upcroft and 
Upcroft, 2001). However, in laboratory strains modest resistance has been induced up 
to a concentration of 40 µM metronidazole (Wassmann et al., 1999), a lethal dose in 
unadapted amoebae. In this resistant line, the expression of superoxide dismutase and 
peroxiredoxin was increased, the expression of ferredoxin 1 was decreased, whereas 
the expression of PFOR decreased only slightly. 
Metronidazole resistance in Giardia and Trichomonas is a severe clinical 
problem, as for instance in Giardia up to 20% of clinical cases show resistance (Ali and 
Nozaki, 2007). In these cases, PFOR is significantly down-regulated, what was thought 
to be the mechanism of metronidazole resistance in Giardia. Even multidrug-resistant 
strains can be grown. In Trichomonas, resistance in vivo can even develop with 
therapeutic levels of metronidazole and is also associated with the down-regulation or 
even loss of PFOR and ferredoxin, showing the differences of metronidazole resistance 
in the “amitochondirates”.  
All these data show the increasing problems with metronidazole resistance in 
anaoerobic parasites. As only a limited number of other chemotherapeuticals against 
these organisms are available and resistance against these has also been observed, it 
is clear that the search for new chemotherapeutic agents must go on or even be 
intensified.  
Other protozoan parasites show similar developments concerning resistance. 
The probably most important example for these problems is the genus Plasmodium, 
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where the burden of disease and the number of deaths each year is far greater, but the 
regions with multiresistant strains grow (Nzila and Mwai, 2009), and even resistance 
against artemisinin has been observed (Noedl et al., 2008 and 2009). Therefore, the 
search for new chemotherapeuticals is an urgent duty.  
Taken together, the crucial necessity for further research on chemotherapy of 
protozoan parasites is obvious. What is more, often the exact mode of action of widely 
used chemotherapeutic agents is not known. Regarding metronidazole, this gold 
standard drug is in use for more than 50 years now, and there has been a lot of 
research on its activation in the parasites, but the exact mode of action is still not fully 
understood and merits further experimental work.  
Metronidazole in its genuine form is not active but needs to be reduced at the 
nitro group to become the active nitroradical anion that has cytotoxic properties (Müller, 
1983). This nitroradical anion is further reduced to a nitrosoimidazole (Moreno and 
Docampo, 1985) that is able to react with sulfhydryl groups (West et al., 1982) and with 
DNA (Ludlum et al., 1988). Ongoing reduction leads to the formation of a hydroxylamine 
and finally to an amine. This activation pathway can only happen in the anaerobic 
environment e.g. in the parasites discussed here. In an aerobic environment like in 
humans the nitroradical anion is immediately reoxidized in a so-called futile cycle 
(Mason and Holtzmann, 1975), leading to the formation of superoxide radical anions 
and oxidative stress, but no severe cell damage. This reoxidation is the reason why 
nitroimidazoles are considered safe for use in humans, although the risk of cancer 
development because of the oxidative stress could not conclusively be ruled out by a 
number of studies (Bendesky et al., 2002).  
The enzymes responsible for reduction of the nitro group have been examined 
extensively, and several candidates were found. Ferredoxin was proposed as the main 
reducing agent, this iron-sulfur protein is reduced itself by pyruvate:ferredoxin 
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oxidoreducase (PFOR) (Müller 1986). In T. vaginalis, both enzymes are located in the 
hydrogenosome, and activation of metronidazole was found to take place there 
(Chapman et al., 1985). Nevertheless, parasites in which ferredoxin was knocked out 
did not display full resistance to metronidazole, suggesting the existance of other 
pathways of metronidazole activation, a possible alternative being malic enzyme 
(Rasoloson et al., 2002). Recent findings from our group show that the flavin enzyme 
thioredoxin reductase can reduce and activate metronidazole and other nitroimidazoles 
at significant rates in E. histolytica (Leitsch et al., 2007) as well as in T. vaginalis 
(Leitsch et al., 2009; 2010). For further discussion see point 4 (Conclusions).  
The mode of action in vivo of metronidazole is still not fully understood. It is 
supposed to react with DNA (Ludlum et al., 1988), leading to damage, but no binding to 
specific enzymes has been found until recently, as the mechanism of cytotoxicity was 
thought to be random.  
The recent sequencing of the genomes of the anaerobic parasites E. histolytica 
(Loftus et al., 2005), Giardia lamblia (Morrison et al., 2007) and T. vaginalis (Carlton et 
al., 2007) really simplifies the research on mode of action of chemotherapeuticals, gene 
expression and many other aspects of the biology of these organisms. The availability 
of the complete sequences enables researchers to use various techniques for resolving 
scientific questions, e.g. microarray studies, qRT-PCR (quantitative real-time reverse 
transcription PCR) or two-dimensional gel electrophoresis (2DE).  
 
1.3 Methods 
1.3.1 The use of microarray studies in parasite research 
 DNA microarrays of the kind we know today were developed only some 15 years 
ago (Shalon et al., 1996). They mostly consist of a glass slide with modified surface 
properties onto which the target DNAs (genomic DNA, cDNA or oligonucleotides) are 
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spotted in a defined manner so to know which target DNA is found in which location. 
Then the probes of interest are prepared for hybridization onto the slide. For example, 
mRNAs are extracted from cells in two different conditions. The mRNAs are transcribed 
into cDNAs labeled with fluorescent dyes, mostly Cy3 and Cy5, and incubated with the 
microarray slides where hybridization of the complementary sequences can take place. 
After hybridization, excess probe is washed off, the slides dried and analysed with the 
help of a laser scanner microscope and camera. Data are stored and analysed with 
appropriate computer programs.  A good overview of the technique is found in the NCBI 
factsheet on microarrays at http://www.ncbi.nlm.nih.gov/About/primer/microarrays.html. 
The greatest handicap of microarrays at the beginning were the high costs for these 
experiments so that only large institutes had the resources to really use this interesting 
method. 
 Perhaps the most intriguing feature of microarray studies is the fact that the 
whole genome can be studied in one experiment. The effect of, for instance, 
chemotherapeutical treatment, stress like heat shock or UV-radiation, or the change in 
nutritional conditions can be monitored on a whole genome scale. Therefore it is not 
surprising that with the availability of the sequence data through the Entamoeba 
histolytica genome project (Loftus et al., 2005) the number of published mircoarray 
studies grew rapidly. Different microarray platforms were used, e.g. arrays on the 
commercially available Affymetrix™ platform (www.affymetrix.com) versus selfspotted 
arrays, long or short oligonucleotide arrays versus cDNA arrays.  
A variety of topics have already been investigated. The reaction of E. histolytica 
to stress by UV irradiation that caused DNA damage was studied by Weber et al. 
(2009). The overall change in gene expression 5 min after the UV-treatment was very 
limited, with only a few genes regulated stronger than 2-fold. Three hours after the UV-
C irradiation the response was more pronounced but still limited to only a few genes 
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regulated stronger than 2-fold. The same research group has looked into amoebic 
response to heat shock (Weber et al., 2006). Surprisingly, a massive overall down-
regulation of expression levels was found (471 genes), with only 40 genes up-
regulated, including heat shock proteins and two cysteine proteinases 4 and 6, whereas 
a lot of pathogenicity factors including all other cysteine proteinases, peroxiredoxin and 
amoebapore C were down-regulated. 
The impact of oxidative and nitrosative stress on E. histolytica HM-1:IMSS was 
surveyed by Vicente et al. (2009). There were a large number of genes modulated by 
both stressors, including heat shock proteins, ubiquitin-conjugation enzymes or protein 
kinases. Interestingly, when subjecting the non-pathogenic strain E. histolytica Rahman 
to the same stressors, there were marked differences in the response of the cells and 
they seemed to suffer greater damage from oxidative stress, perhaps partly explaining 
the decreased pathogenicity of this strain.  
The same group examined developmentally regulated genes in E. histolytica 
upon stage conversion between trophozoite and cyst (Ehrenkaufer et al., 2007b). Using 
parasite strains from very recent human infections they found 672 genes enriched in the 
cyst stage including cysteine proteinases and transmembrane kinases. Of the 767 
genes enriched in trophozoites many are thought to be important for tissue invasion like 
the Gal/GalNAc lectin light subunit. Some of the genes were also found to be 
developmentally regulated in E. invadens, hinting at a conserved mechanism in 
Entamoeba stage conversion. 
Pathogenicity has always been an important topic in Entamoeba research, so 
several microarray studies focus on this issue. Tillack et al. (2007) looked at the 
peptidases of E. histolytica because especially the cysteine peptidases are regarded as 
major pathogenicity factors of this parasite. Using a small focussed array, they 
investigated seven different E. histolytica isolates for the expression levels of the 50 
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cysteine peptidases and more than 30 other peptidases they had found in the amoeba 
genome, under normal conditions and also under heat stress. Surprisingly, the overall 
expression level of these genes was rather low, with only a relatively small number 
significantly expressed, also when comparing different strains and stress conditions, so 
the role of peptidases in Entamoeba pathogenicity merits further investigation. Strain 
comparison has been the topic of a study by Davis et al. (2007) who found 353 genes 
differentially expressed between E. histolytica HM-1:IMSS and Rahman, with distinct 
patterns for cysteine proteinases, lectin light chains and AIG (avirulence induced gene) 
family members. Differences in the expression level of genes similar to the AIG1 plant 
antibacterial proteins were also found by Gilchrist et al. (2006), who investigated the 
impact of intestinal colonization and tissue invasion on the E. histolytica transcriptome. 
They compared trophozoites isolated from the colon of infected mice with in vitro 
cultures and found 523 transcripts significantly changed between the two cultures, 
including genes implicated in metabolism, oxygen defense, cell signalling or virulence.  
Two recent papers look at the effects of histone modifications in the E. histolytica 
genome. Isakov et al. (2008) treated the parasites of strain HM-1:IMSS with 50nM 
trichostatin A (TSA), an inhibitor of histone deacetylase. They found enhanced 
cytopathic and hemolytic activity of the amoebae as well as increased peroxiredoxin 
expression, corresponding to increased resistance to oxidative stress. On the whole, 13 
genes were up- and 31 genes down-regulated by TSA-treatment. Jacob, the most 
abundant glycoprotein of the amoebic cyst wall, was up-regulated threefold by TSA. 
Only one gene was commonly up- and two others down-regulated compared with the 
second TSA-study, conducted by Ehrenkaufer et al. (2007a). Here the E. histolytica 
strain 200:NIH was treated with 150 nM of TSA, resulting in 122 genes being up- and 
41 genes being down-regulated. Interestingly, a strong overlap existed between genes 
up-regulated by TSA exposure and genes found induced in cysts. Amoeba treatment 
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with 5-azacytidine, an inhibitor of DNA-methyltransferase, did not regulate genes 
modulated by TSA, indicating that no substancial connection is found between these 
two methods of epigenetic modulation of gene expression.  Additionally, the influence of 
short chain fatty acids on amoebae was investigated, as these molecules also alter 
histone acetylation patterns. But only a weak transcriptional change was seen (11 out of 
9435 genes regulated).  
 Of course microarrays have also been used for different applications in other 
protozoan parasites. For instance, transcriptional and genomic analysis of Plasmodium 
falciparum field isolates compared to long-term in vitro cultivated parasites was 
performed by Mackinnon et al. (2009). Another recent study focusses on the effect of 
Plasmodium infection on host cell gene expression in the liver (Albuquerque et al., 
2009). 
In Giardia lamblia, gene expression of a clone resistant to metronidazole and 
nitazoxanide was in focus of a study by Müller et al. (2008). They found that resistance 
was correlated with changes in expression patterns of major surface antigens and also 
of heat shock proteins. Microarrays can also be used for the detection and genotyping 
of multiple protozoan parasites in environmental samples, as shown in a study by Wang 
et al. (2004). They designed a microarray able to distinguish between E. histolytica and 
dispar, 3 different G. lamblia assemblages and two types of Cryptosporidium parvum.  
  This short overview shows the wide variety of applications possible for 
microarray technique with regard to protozoan parasites. The focus of this doctoral 
thesis project lay on the construction of a focussed microarray to detect the effects of 
metronidazole treatment on E. histolytica gene expression. For the details of this study 
see point 2 (Aims of this study) and point 3 (Manuscripts).  
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1.3.2 Quantitative real-time RT-PCR (qRT-PCR) for investigating gene 
expression in parasites 
 Quantitative real-time reverse transcription - polymerase chain reaction, 
commonly abbreviated as qRT-PCR, is another fast evolving method that emerged 
more or less at the same time as microarrays (Heid et al., 1996). It is a further 
development of PCR technique that is able to reliably detect and measure the products 
of PCR during each cycle of the process. There are several methods in use. The 
TaqMan assay uses a forward and reverse primer as well as an oligonucleotide 
hybridisation probe that binds within the sequence of the gene of interest. This probe 
carries a fluorophore at the 5’-end and a quencher molecule at the 3’-end. As long as 
these two are in close proximity, the quencher inhibits fluorescence. During extension of 
the newly synthezised strand the 5’ to 3’ exonuclease activity of the TaqPolymerase 
degrades the hybridisation probe, setting free the reporter fluorophore from the 
quencher. The fluorescence that is detectable now is proportional to the amount of 
newly synthezised DNA (Heid et al., 1996). 
 Another method uses SYBR green fluorescence. This substance binds only to 
double-stranded DNA that is generated during the amplification process of the PCR 
cycles. The more dsDNA is present, the more SYBR green binds and the signal gets 
more intensive. A good overview of this method can be found at 
http://pathmicro.med.sc.edu/pcr/realtime-home.htm 
The qRT-PCR method is rather easy to perform nowadays, with sophisticated 
equipment and many different chemicals available. But of course there are several 
important points to consider that can influence the quality and informative value 
dramatically, for instance assay design, the choice of internal controls or analysis tools. 
Therefore the establishment of best practice guidelines and accepted evaluation tools is 
 
- 22 -
a vital issue for the future relevance of this technique (see for instance Bustin, 2009; 
Nolan et al., 2006).  
The applications of real-time qRT-PCR are manifold, e.g. relative and absolute 
quantification of gene expression, variation analysis or the validation of microarray 
results. We also used real-time qRT-PCR to control our microarray results, for the 
details see point 3.4 (manuscript).   
 
1.3.3     Two-dimensional gel electrophoresis (2DE) for the study of whole 
parasite proteomes 
 Gene expression profiling is one part of investigating how a cell reacts to stress, 
chemotherapeuticals etc. The other part concerns effects on the proteome, to which 
extent alterations in gene expression actually correlate with changes in protein 
abundance or de novo synthesis (de Sousa Abreu et al., 2009;  Tian et al., 2004). So it 
is ideal to combine gene expression profiling with proteomics methods. The most 
commonly used method is 2DE (Görg et al., 2004), consisting of isoelectric focusing of 
solubilized proteins in an immobilized pH gradient gel according to their respective 
isoelectric point, and subsequently, separation of proteins according to their molecular 
weight on an SDS-polyacrylamide gel. In this way a high resolution of proteins can be 
realised, which afterwards can be visualised by staining with Coomassie Brilliant Blue, 
silver or fluorescent dyes. Relative quantitative analysis of the gels is possible with 
imaging programs, for qualitative analysis, the protein spots of interest can be cut from 
the gel and subjected to various mass spectrometric methods. With the help of genomic 
data the actual proteins can be elucidated.  
This method can of course be used for parasite proteomes, what was greatly 
simplified by the dfferent genome projects published in the last years. For instance, a 
proteome reference map of T. vaginalis was published recently (Huang et al., 2009). 
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Pathogenicity is an important topic in this parasite, one study looked at the proteomes 
of one long-term grown and one freshly isolated strain of T. vaginalis that exhibited 
marked differences in pathogenicity (Cuervo et al., 2008). Nineteen proteins 
overexpressed in the highly virulent strain were characterised. In Giardia research, a 
recent review compares proteomic studies from the pre- and post-genomic era (Steuart, 
2010). As stage conversion is of great interest in Giardia, one research group compared 
the proteomes of trophozoites versus cysts (Kim et al., 2009). Proteomic studies are 
also of great relevance in elucidating the processes in different stages of Plasmodium 
parasites, for instance in the liver (Tarun et al., 2008).  
Concerning Entamoeba histolytica and 2DE gels, only a few studies have been 
published, as other research groups use other proteomics methods like 2D-DIGE. The 
first 2DE study was published in 2005 by Leitsch et al. and was a proof of principle for 
this method with this parasite, furthermore several proteins were identified. Tolstrup et 
al. (2006) published another protocol of 2DE in E. histolytica. Comparison of amoebae 
with different pathogenicity was the subject of two more research projects. In one case 
the E. histolytica HM-1:IMSS proteome was compared to avirulent E. histolytica 
Rahman (Davis et al., 2006), in the other study the former was compared to non-
pathogenic E. dispar SAW 760 (Leitsch et al., 2006).  
2DE complemented the transcriptomic analysis of the effect of metronidazole on 
E. histolytica in this study, for the results see point 3.4 (manuscript) and point 4, the 
Conclusions section.  
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2 Aims of this study 
Three main goals of the thesis can be described as follows: 
1) Compilation of databases containing genome information on Entamoeba 
histolytica. When we started this project, no genome annotation was available, 
so we had to prepare our own annotation databases as basic information 
necessary for the subsequent construction of our microarray. Furthermore in the 
course of information assemblage we hoped to get on overview about the 
genome of the parasite, e.g. how big is the proportion of genes with bacterial 
background, which metabolic pathways are present/absent in the genome, what 
substances can E. histolytica synthesise itself and which are taken up from the 
host.  
2) Establishment of microarray technology in our laboratory for the accomplishment 
of this project and perhaps for future projects. 
3) With the help of a focussed oligonucleotide microarray investigation of the gene 
expression of E. histolytica under metronidazole treatment. We wanted to find 
out how the parasite reacts to this chemotherapeutical stress, which genes or 
pathways are involved in the response to metronidazole. Additionally we were 
interested in the mode of action of metronidazole, what it does to the cell and 
why the cells cannot cope with this substance. Genes found to be involved in the 
response to metronidazole could point to processes in the establishment of 
resistance.  
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3 Manuscripts 
 
 
3.1 Entamoeba histolytica: construction and applications of 
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Abstract
Knowledge about the inXuence of environmental stress such as the action of chemotherapeutic agents on gene expression in Ent-
amoeba histolytica is limited. We plan to use oligonucleotide microarray hybridization to approach these questions. As the basis for
our array, sequence data from the genome project carried out by the Institute for Genomic Research (TIGR) and the Sanger Insti-
tute were used to annotate parts of the parasite genome. Three subgenomic databases containing enzymes, cytoskeleton genes, and
stress genes were compiled with the help of the ExPASy proteomics website and the BLAST servers at the two genome project sites.
The known sequences from reference species, mostly human and Escherichia coli, were searched against TIGR and Sanger E. histoly-
tica sequence contigs and the homologs were copied into a Microsoft Access database. In a similar way, two additional databases of
cytoskeletal genes and stress genes were generated. Metabolic pathways could be assembled from our enzyme database, but some-
times they were incomplete as is the case for the sterol biosynthesis pathway. The raw databases contained a signiWcant number of
duplicate entries which were merged to obtain curated non-redundant databases. This procedure revealed that some E. histolytica
genes may have several putative functions. Representative examples such as the case of the -aminolevulinate synthase/serine palmi-
toyltransferase are discussed.
  2005 Elsevier Inc. All rights reserved.
Index Descriptors and Abbreviations: EC, enzyme commission; LGT, lateral gene transfer; ORF, open reading frame
Keywords: Entamoeba histolytica; Genome project; Database; Enzyme; Cytoskeleton; Stress response1. Introduction
Entamoeba histolytica causes up to 100,000 deaths per
year and represents a major health problem especially in
developing countries (WHO, 1997). The E. histolytica
genome project (Loftus et al., 2005) carried out by the
Wellcome Trust Sanger Institute in Hinxton, Cambridge
(UK) and the Institute for Genomic Research (TIGR) in
Rockville, Maryland (USA), creates many new opportu-
nities for the scientiWc community. Hopes are high to
* Corresponding author. Fax: +43 1 4277 64899.
E-mail address: michael.duchene@meduniwien.ac.at (M. Duchêne).0014-4894/$ - see front matter   2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.exppara.2005.03.018gain new insights into the molecular mechanisms of
amoebiasis and Wnd new targets for chemotherapy.
In our laboratory we plan to monitor the eVects of
metronidazole and alkylphosphocholines on the gene
expression of E. histolytica with the help of oligonu-
cleotide microarrays. Microaerophilic E. histolytica
reduces the nitro group of metronidazole to cytotoxic
nitro radicals via its reduced ferredoxin (Wassmann
et al., 1999). Little is known about the mode of action
of alkylphosphocholines such as miltefosine, but it is
believed to interact with the lipid metabolism of the
cells (Croft et al., 2003). Hybridization of drug-treated
and control cDNAs to a focussed microarray with all
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their lipid metabolism enzymes could be an appropriate
way to gain insight into the mechanism of action of the
two chemotherapeutic agents. When we started our work,
the genome sequences had not yet been annotated, there-
fore we had to compile our own database with genome
information. A software program for such a database
should be stable, create highly convertible data sets,
be Xexible, and easy to use and maintain. We decided to
use the Microsoft Access database software. Here we
describe the compilation of three diVerent subgenomic
databases containing enzymes, cytoskeleton genes, and
stress genes found in the E. histolytica genome.
2. Materials and methods
The Microsoft Access 2000 database software was
chosen as program for compiling our data. First we
selected enzymes with known protein sequences from the
web version of the Roche Applied Science (previously
Boehringer–Mannheim) Biochemical Pathways (http://
us.expasy.org/cgi-bin/show_thumbnails.pl). We followed
the link to the ExPASy website (http://www. expasy.org/)
with the Swiss-Prot and Trembl (http://www.expasy.
org/sprot/) as well as the Enzyme (http://www.
expasy.org/enzyme/) databases, where reference protein
sequences for these enzymes were retrieved. These were
used for a tblastn search with default settings against the
TIGR (http://tigrblast.tigr.org/er-blast/index.cgi?project
D eha1) and Sanger (http://www.sanger.ac.uk/cgi-bin/
blast/submitblast/e_histolytica) DNA sequences of the
E. histolytica genome project. Tblastn compares a pro-
tein query sequence against a nucleotide sequence data-
base dynamically translated in all six reading frames
(both strands) using the BLAST algorithm (Altschul
et al., 1990). The tblastn output top hits were considered
a signiWcant match if their P values were in the range of
10¡5or better (lower than 9.9E¡05), and a complete
database entry was generated. We also recorded the
cases where no signiWcant match was found. The exact
position of the homologous sequence in the contig was
established with the help of the Expasy translate tool
(http://www.expasy.org/tools/dna.html) as well as the
UWGCG package (Program Manual for the Wisconsin
Package Version 8.1-Unix, see References). The theoreti-
cal isoelectric point (pI) and molecular weight of the
found homolog were calculated with the help of the
ExPASy pI/Mw tool (http://www.expasy.org/tools/
pi_tool.html). In total, a set of up to 30 parameters were
recorded for each database entry. Biochemical pathways
including all found E. histolytica enzyme homologs were
established with the help of the Kyoto Encyclopedia of
Genes and Genomes (KEGG) website (http://www.
genome.jp/kegg/tool/search_pathway.html) and dis-
played in comparison to the Standard Data Set.3. Results and discussion
3.1. Establishment and use of the annotation databases
The purpose of our database work was to get a collec-
tion of annotated E. histolytica genes which should be
the basis of our focussed oligonucleotide microarray.
Although we planned to speciWcally target enzymes of
the lipid metabolism and those known to be involved in
reactions to metronidazole chemotherapy, we also
wanted to get an overall picture of the metabolism of
E. histolytica. Therefore we searched for all enzymes in
the Roche/Boehringer “Biochemical Pathways” chart. In
addition, we tried to Wnd homologs of a list of cytoskele-
ton genes and stress genes. For better organisation we
compiled three independent databases of enzymes, cyto-
skeleton genes, and stress genes.
A number of data sets were extracted for each gene into
our Microsoft Access database. Each homologous E. his-
tolytica sequence found with a P value in the range of 10¡5
or better was used to generate a complete database entry.
The P value and the percentage of protein sequence iden-
tity were entered. For the reference sequence the accession
number, the enzyme commission number, and the species
were recorded, as well as how many hits had been found in
total. Next, we entered the E. histolytica protein coding
DNA sequence, the deduced open reading frame (ORF),
the position of the ORF within the contig, if it was a full-
length ORF, and the theoretical pI/Mw. References were
given where E. histolytica genes had been published
before, and suYcient space for comments was included,
for example, we recorded if there were conXicts with the
published sequence. Recently we also introduced a Weld
for the date of last revision to keep track of changes.
For classiWcation of the entries we introduced status
numbers ranging from 1 to 6. Number 1 means a pub-
lished E. histolytica gene sequence, 2 is a sequence with
high degree of end-to end similarity, 3 a sequence with
intermediate degree of similarity, 4 a sequence with weak
similarity, 5 means that there was a sequence for search-
ing but no homology found, and 6 indicates that the
enzyme activity is known but there is no protein refer-
ence sequence in the databases for searching.
The intermediate result of our searches after going
through the Biochemical Pathways chart was that out of
1536 enzyme genes searched for, 962 genes with at least
some sequence similarity (status 1–4) were detected,
searching for 295 cytoskeleton genes led to 281 hits (sta-
tus 1–4), and 109 hits were obtained by searching for 120
putative stress-related genes.
Inspection of the databases revealed that the same
E. histolytica genes sometimes had been detected in diVer-
ent searches. When performing a tblastn search with
human alcohol dehydrogenase -chain (EC 1.1.1.1; Acces-
sion No. P07327) for instance, we obtained three weakly
homologous E. histolytica sequences which were entered
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found when searching with seven other dehydrogenases,
for example, sorbitol dehydrogenase (EC 1.1.1.14;
Q00796). So our databases were examined for redundant
entries. The sequence with the closest similarity was kept
as an entry whereas those with weaker P value and per-
centage of identity were merged with this entry. Informa-
tion on all merged entries was entered in the comments
Weld to be able to reconstruct the original Wndings. On the
whole, this merging process shrinked the enzyme database
from an initial number of 962 to 749 entries with status
1–4 which is a decrease of 213 or approximately 22% of the
entries. At the moment 156 entries consist of two or more
merged entries with the majority of 106 being made up
from two former entries, 30 from three, 14 from four, and
6 from more than four previous entries.
In the same way, the cytoskeleton database was
reduced by 28% from 281 to 202 entries, 41 entries were
merged with 24 being made up from two, 8 from three, 4
from four and 5 from more than four previous entries.
Myosin heavy chain (Raymond-Denise et al., 1993) was
found to be the best hit for a number of reference gene
sequences. The stress gene database was reduced from
120 to 117 entries.
During compilation of our enzyme database we
found a large number of genes where only a tblastn
search with a prokaryotic reference sequence gave sig-
niWcant hits. This remarkable occurrence of bacterial
sequences in E. histolytica has been noted before, and
several candidates for lateral gene transfer (LGT) have
been described (e.g., Kumar et al., 1992; Rosenthal et al.,
1997; Sanchez et al., 2002). The genome project paper
identiWes 96 genes for which LGT is most probable by
stringent criteria (Loftus et al., 2005). We did not do the
same analysis of our candidates for LGT, but our Wnd-
ings support the results of the genome paper.
The design of oligonucleotides for our microarray
experiments was started after completion of the dat-
abases. We chose enzymes that might be inXuenced by
metronidazole or alkylphosphocholines for our focused
array, and added a strong group of housekeeping genes
from glycolysis and cytoskeleton genes as internal con-
trols. For the actual oligonucleotide design from the
gene sequences, we used the software OligoWiz 1.0
which optimizes the length, melting temperature, and
position of the oligonucleotide, and minimizes possible
cross-hybridization with other sequences in the genome
(Nielsen et al., 2003). Our initial microarray consists of
221 oligonucleotides, and preliminary hybridization
experiments are currently performed (results not shown).
3.2. An example for an incomplete metabolic pathway: 
steroid biosynthesis
With the help of the Kyoto Encyclopedia of Genes
and Genomes (KEGG) website, we could generate meta-bolic pathways from the enzyme commission (EC) num-
bers of all the enzymes we had been able to detect. In this
way, a number of pathways, in particular those active in
catabolism such as the glycolytic pathway, were recon-
stituted. Biosynthetic pathways were often absent or
incomplete, as the parasitic microorganism can obtain a
number of building blocks from its host.
For the case of the sterol biosynthesis pathway
(Schroepfer, 1981), we obtained an interesting result. It
has been reported that E. histolytica in culture needs
cholesterol for growth (Reeves, 1984). In agreement with
this Wnding there is no complete sterol biosynthesis path-
way. No enzymes leading through mevalonate to isopen-
tenyl- or dimethylallyl-diphosphate were found, also the
mevalonate-independent methylerythritol 4-phosphate
(MEP) pathway (Hunter et al., 2003; Rohmer et al.,
1993) present in bacteria and plants was not detected.
Unexpectedly, however, we found homologs of iso-
pentenyldiphosphate isomerase (EC 5.3.3.2; 33.1%
sequence identity to Bacillus subtilis, P50740) which
catalyses the conversion between isopentenyldiphos-
phate and dimethylallyl diphosphate. This gene is one of
the candidates of LGT from bacteria (Loftus et al.,
2005). The two isomeric isoprenyl diphosphates undergo
condensation to geranyl diphosphate, and to farnesyldi-
phosphate by addition of a further molecule of isopente-
nyl diphosphate. Both activities, dimethylallyltransferase
(EC 2.5.1.1) and geranyl isopentenyldiphosphate trans-
ferase (EC 2.5.1.10) reside in a single polypeptide chain
with 33.3% identity to Methanococcus jannaschii
(Q58270). The gene coding for this bifunctional enzyme
is also in the LGT candidate list. No presqualene
synthase (EC 2.5.1.21) was detected, but a
geranylgeranyldiphosphate synthase (EC 2.5.1.29). So
the amoebae appear to be able to produce the C10, C15,
and C20 isoprenoid compounds but not the C30
cholesterol precursor.
Another vitally important function of farnesyl- and
geranylgeranyl-residues is to modify the hydrophobicity
of proteins, e.g., for their interaction with membranes
(Grünler et al., 1994). Indeed the genome contains
sequences for the - and -chains of a protein farnesyl-
transferase (EC 2.5.1.58), which have been cloned and
characterized on the recombinant protein level
(Kumagai et al., 2004). Protein farnesylation is an impor-
tant novel target of anti-parasitic chemotherapy
(Maurer-Stroh et al., 2003) including anti-E. histolytica
chemotherapy (Ghosh et al., 2004). Besides the protein
farnesyltransferase, there are two genes encoding the
identical sequence of a putative Type I protein geranyl-
geranyltransferase (EC 2.5.1.59)  chain and the - and
-chains of a putative Type II (Rab-) geranylgeranyl-
transferase (EC 2.5.1.60). In addition, there are putative
homologs of the CAAX prenyl protease (EC 3.4.24.84)
and the prenyl cysteine carboxyl methyltransferase (EC
2.1.1.100) which further modify prenylated proteins.
M. Hofer, M. Duchêne / Experimental Parasitology 110 (2005) 178–183 181So the described pathway from isopentenyldiphosphate
may mainly serve to provide precursors for protein pre-
nylation. Since cholesterol biosynthesis cannot be com-
pleted, the amoebae depend on cholesterol from thehost. Currently the question is open, however, how the
amoebae may acquire the isopentenyldiphosphate.
Certainly more biochemical work is needed to under-
stand these data.Fig. 1. (A) -Levulinate synthase (EC 2.3.1.37) is involved in heme biosynthesis and (B) serine palmitoyltransferase (EC 2.3.1.50) in sphingolipid bio-
synthesis. These two enzymes catalyze related reactions, their sequences, however, are only distantly related in humans. In contrast, there is only one
homologous enzyme in E. histolytica, so far with unknown substrate speciWcity.Fig. 2. The enzymes (A) dihydropyrimidinase (EC 3.5.2.2) and dihydroorotase (EC 3.5.2.3) and (B) allantoinase (EC 3.5.2.5) all catalyze the cleavage
of amide bonds in diVerent molecules, in E. histolytica there is only one homolog with unknown substrate speciWcity.
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In humans the enzyme -levulinate synthase is
involved in the early steps of heme biosynthesis, whereas
serine palmitoyltransferase is required for the synthesis
of sphingolipids (Merrill, 2002). Although, at the Wrst
glance, the two enzymes appear to be unrelated, Fig. 1
shows that they both catalyze the head-to-head conden-
sation of an amino acid with an acyl-CoA species liber-
ating CoA and CO2. In addition both use the cofactor
pyridoxal phosphate. In humans -levulinate synthase
(EC 2.3.1.37; P22557) and serine palmitoyltransferase
(EC 2.3.1.50; O15269) are only 22.3% identical on the
amino acid level, they share 27.7 and 25.4% sequence
identities, respectively, with their closest E. histolytica
homolog. Surprisingly, these two homologs are identical,
there is only one gene in E. histolytica.
A further example shown in Fig. 2 is the case of the
amide bond-cleaving enzymes dihydropyrimidinase (EC
3.5.2.2), dihydroorotase (EC 3.5.2.3), and allantoinase
(EC 3.5.2.5). Searching for all three enzyme homologs is
successful, but there is only one E. histolytica sequence.
At this point the substrate speciWcity of this gene prod-
uct is not known as is the case for the putative -levuli-
nate synthase/serine palmitoyltransferase. In each of
these cases more biochemical work with isolated or
recombinant enzymes is required.
The presented work clearly demonstrates the evolving
character of the genome project as well as the opportuni-
ties gained from it. Of course databases like ours always
need to be modiWed because of new Wndings, e.g., closure
of sequence gaps or characterization of the function of
hypothetical genes. This permanent updating and curation
will be essential to preserve the value of the databases. We
hope that our funding will allow such work in the future.
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Entamoeba histolytica is an intestinal parasite and the causative
agent of amoebiasis, which is a significant source of morbidity
and mortality in developing countries1. Here we present the
genome of E. histolytica, which reveals a variety of metabolic
adaptations shared with two other amitochondrial protist patho-
gens: Giardia lamblia and Trichomonas vaginalis. These adap-
tations include reduction or elimination of most mitochondrial
metabolic pathways and the use of oxidative stress enzymes
generally associated with anaerobic prokaryotes. Phylogenomic
analysis identifies evidence for lateral gene transfer of bacterial
genes into the E. histolytica genome, the effects of which centre
on expanding aspects of E. histolytica’s metabolic repertoire. The
presence of these genes and the potential for novel metabolic
pathways in E. histolytica may allow for the development of new
chemotherapeutic agents. The genome encodes a large number of
novel receptor kinases and contains expansions of a variety of
gene families, including those associated with virulence.
Additional genome features include an abundance of tandemly
repeated transfer-RNA-containing arrays, which may have a
structural function in the genome. Analysis of the genome
provides new insights into the workings and genome evolution
of a major human pathogen.
Genome analysis was carried out on a 12.5-fold coverage genome
assembly consisting of 23,751,783 base pairs (bp) distributed among
888 scaffolds. The 9,938 predicted genes average 1.17 kilobases (kb)
in size and comprise 49% of the genome. One-quarter of
E. histolytica genes are predicted to contain introns, with 6% of
genes containing multiple introns. No homologues could be identi-
fied for a third of predicted proteins (31.8%) from the public
databases (see Methods). E. histolytica chromosomes do not con-
dense, and the uncertainty surrounding its ploidy and the extensive
length variability observed between homologous chromosomes
from different isolates makes the exact chromosome number
difficult to determine. The chromosome size variation observed
may be due to expansion and contraction of subtelomeric repeats, as
in other protists2,3, and it is tempting to speculate that in
E. histolytica these regions consist of tRNA-containing arrays.
Comprising almost 10% of the sequence reads, 25 types of long
tandem array, each containing between one and five tRNA types per
repeat unit, could be identified from the genome data. The full
complement of tRNAs required for translation has been identified,
and all but four of the tRNA genes are encoded exclusively in arrays.
These unique tRNA gene arrays are thus predicted to be functional
as well as potentially fulfilling a structural role in the genome. No
association could be determined between codon usage and the
relative copy numbers of their cognate tRNA species.
The metabolism of E. histolytica seems to have been shaped by
secondary gene loss and lateral gene transfer (LGT), primarily from
bacterial lineages (Fig. 1). E. histolytica is an obligate fermenter,
using bacterial-like fermentation enzymes and lacking proteins of
the tricarboxylic acid cycle and mitochondrial electron transport
chain. An atrophic, mitochondrion-derived organelle has been
identified in E. histolytica4, and the genome data support the
absence of a mitochondrial genome. Glucose is the main energy
source; however, in place of the typical eukaryotic glucose trans-
porters those of E. histolytica are related to the prokaryote glucose/
ribose porter family, with the amino- and carboxy-terminal
domains switched relative to their prokaryotic counterparts.
As a phagocytic resident of the human gut, E. histolytica has
access to many bacterial and host-derived preformed organic
compounds. Most pathways for amino acid biosynthesis have
been eliminated, except those for serine and cysteine, which are
probably retained for the production of cysteine, the major intra-
cellular thiol. The high levels of cysteine in E. histolytica
may compensate for the lack of glutathione and its associated
enzymes, a major component of oxidative stress resistance in
many organisms5. E. histolytica lacks de novo purine, pyrimidine
and thymidylate synthesis and must rely on salvage pathways,
similar to G. lamblia and T. vaginalis6. In addition, E. histolytica
appears to lack ribonucleotide reductase, a characteristic that it
shares with G. lamblia7. E. histolytica is unable to synthesize fatty
acids but retains the ability to synthesize a variety of phospholipids.
The absence of identifiable pathways for the synthesis of isoprenoids
and the sphingolipid head group aminoethylphosphonate suggest
the existence of novel pathways. These pathways, once character-
ized, might represent attractive drug targets. Two unusual enzymes
of fatty acid elongation are shared between E. histolytica and
G. lamblia, including a predicted acetyl-CoA carboxylase with two
carboxyltransferase domains8. We propose that this enzyme
removes a carboxyl group from oxaloacetate and transfers it to
acetyl-CoA to form malonyl-CoA and pyruvate. E. histolytica also
has five members of a fatty acid elongase family, previously
identified only in plants, green algae and G. lamblia9,10. Folate is
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a cofactor essential for thymidylate synthesis and methionine re-
cycling, and genome analysis reveals a complete lack of genes coding
for known folate-dependent enzymes and folate transporters. Folate
is also required for organelle protein synthesis in mitochondria and
chloroplasts, and loss of the mitochondrial genome may have paved
the way for the loss of these folate-dependent functions.
LGT is an important force in the evolution of prokaryotes but
significantly less is known about its importance in eukaryotic
evolution11. We conducted a phylogenetic screen of the Entamoeba
genome for cases of relatively recent prokaryote to eukaryote LGT
(see Methods), and for 96 genes we believe that this is the simplest
explanation for the tree topologies obtained (see Supplementary
Information). These genes are embedded among typically eukary-
otic genes on E. histolytica scaffolds and do not seem to represent
contaminating prokaryotic sequences. Most (58%) of the LGT
genes encode a variety of metabolic enzymes, whereas most of the
remaining genes (41%) encode proteins of unknown function
(Supplementary Fig. 1). The major impact is in the area of
carbohydrate and amino acid metabolism, where they have
increased the range of substrates available for energy generation
including tryptophanase and aspartase, which contribute to the use
of amino acids. Several glycosidases and sugar kinases appear to
have been acquired through LGT and would probably enable
E. histolytica to use sugars other than glucose; for example, fructose
and galactose. There is a strong bias in the data for a major donor
being in the Cytophaga–Flavobacterium–Bacteroides (CFB) group of
the phylum Bacteroidetes; however, this should be interpreted with
caution, as current sampling of prokaryotic genomes is still rela-
tively incomplete. It is clear that among the 96 genes, some result
in significant enhancements to E. histolytica metabolism, thus
contributing to its biology to a greater extent than indicated by
the numbers alone.
E. histolytica feed on bacteria in the lumen of the colon and lyse
host epithelial cells after invasion of the intestinal wall12. A number
of amoebic virulence determinants have been characterized, includ-
ing a multi-subunit GalGalNAc lectin involved in adhesion to host
cells, cysteine proteases that degrade host extracellular matrix, and
pore-forming peptides (amoebapores) capable of lysing target
cells12. Analysis of the genome reveals redundancy in the genes
encoding these virulence factors. Thirty homologues of the inter-
mediate subunit and one homologue of the heavy subunit of the
GalGalNAc lectin were identified. Ten new cysteine proteinases with
predicted N-terminal transmembrane anchors, which might allow
them to be localized on the amoeba cell surface, were identified. In
addition to three new amoebapores a homologue of haemolysin III
was identified, suggesting that, in addition to amoebapores, haemo-
lysins may have a role in host cell lysis.
Vesicle trafficking has a role in E. histolytica pathogenesis through
phagocytosis and the delivery of secreted hydrolytic enzymes and
amoebapores to the cell surface13. E. histolytica lacks morphologi-
cally identifiable rough endoplasmic reticulum and the Golgi
apparatus14 but encodes the basic elements of the vesicle transport
machinery common to other eukaryotic cells, with the coat com-
plexes COPI, COPII, clathrin and retromer all being present. Rab
and Arf protein family expansions reflect the increased complexity
and number of vesicle fusion and recycling steps that have been
associated with phagocytosis and pinocytosis in amoebae15. The
cytoskeleton has a number of important roles in parasite motility,
contact-dependant killing and phagocytosis of host intestinal epi-
thelial cells16. This is reflected in expansions of Rho GTPases and
their regulators RhoGAPs and RhoGEFs, which control a number of
processes involving the actin cytoskeleton. Five proteins with
a unique domain architecture containing both RhoGEF and Arf-
GAP domains were identified, suggesting a mechanism for direct
Figure 1 Predicted metabolism of E. histolytica based on analysis of the genome
sequence data. Arrows indicate enzyme reactions. Glycolysis and fermentation are the
major energy generation pathways. Green arrows represent enzymes encoded by genes
that are among the 96 candidates for LGT into the E. histolytica genome. Broken arrows
indicate enzymes for which no gene could be identified using searches of the genome
data, although the activity is likely to be present. The yellow arrow points to the source of
electrons for activation of metronidazole, the major drug for treatment of amoebic liver
abscess. DK, pyruvate phosphate dikinase; GlcNAc, N-acetylglucosamine; GPI,
glycosylphosphatidylinositol; K, pyruvate kinase; LCFA, long-chain fatty acid; PAPS,
phosphoadenosine phosphosulphate; PEP, phosphoenolpyruvate; PP, pyrophosphate;
PRPP, phosphoribosyl pyrophosphate; VLCFA, very-long-chain fatty acid.
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communication between the regulators of vesicle budding and
cytoskeletal rearrangement.
E. histolytica uses a complex mix of signal transduction systems in
order to sense and interact with the different environments it
encounters (Fig. 2). Almost 270 putative E. histolytica protein
kinases representing members of all seven families of the eukaryotic
protein kinase superfamily were identified17. These include tyrosine
kinases with SH2 domains, tyrosine kinase-like protein kinases and
90 putative receptor Ser/Thr kinases. These Ser/Thr kinases are
uncommon in protists, appear to be absent from Dictyostelium and
have previously been described only in plants, animals and Choano-
flagellates. The E. histolytica receptor Ser/Thr kinases all contain an
N-terminal signal peptide, a predicted extracellular domain and a
single transmembrane helix followed by a cytosolic tyrosine kinase-
like domain. The receptor kinases fall into three groups on the basis
of differences in their predicted extracellular domains. The first
group of 50 receptor kinase proteins contains CXXC-rich repeats
similar to those found in the intermediate subunit (Igl) of the
Gal/GalNAc lectin and G. lamblia variant-specific surface proteins.
A second group of 32 proteins encodes cysteine-rich domains
containing CXC repeats. The third group of eight receptor kinase-
like proteins lacks cysteine-rich extracellular domains. Although no
immediate downstream effectors to the amoebic receptor kinases
could be identified, E. histolytica contains greater than 100 protein
phosphatases, which dephosphorylate proteins. An unusual feature
of some of the phosphatases is the presence of varying numbers of
leucine-rich repeat (LRR) domains that are involved primarily in
protein–protein interactions and have not previously been associ-
ated with phosphatases. The E. histolytica genome encodes numer-
ous putative seven-transmembrane receptors and trimeric G
proteins, which are probably involved in mediating autocrine
stimulation of encystation18. In contrast to autocrine stimulation
of Dictyostelium sporulation, which uses secreted cyclic AMP,
E. histolytica encystment is self-stimulated by secreted catechol-
amines18. Finally, E. histolytica has numerous cytosolic proteins
involved in signal transduction, including Ras-family proteins,
EF-hand calcium-binding proteins, phosphatidylinositol-3-OH
kinase and MAP kinases. This represents the most varied set of
signal-transduction-related proteins yet described in a single-celled
eukaryote.
In contrast to life in the anoxic colon, E. histolytica encounters a
relatively high-oxygen environment during invasive amoebiasis,
and coping with this change is therefore an important virulence
factor. The importance of this response is underscored by the
redundancy of oxygen detoxification mechanisms. E. histolytica
has four copies of flavoprotein A, which detoxifies nitric oxide
and/or oxygen19 (Fig. 3), and also contains rubrerythrin, which in
anaerobic bacteria is protective against intracellular hydrogen
peroxide20 (Fig. 3). These oxidative and/or nitrosative stress resist-
ance genes are shared with G. lamblia (with the exception of
rubrerythrin) and T. vaginalis, but have generally been associated
with anaerobic prokaryotes (Fig. 3).
E. histolytica is the first amoeba genome to be fully sampled, and
comparisons with other genomes will assist in resolving funda-
mental issues relating to eukaryote and amoeba phylogeny, as well as
how LGTaffects eukaryotes. Despite a lack of representative genome
sampling from amitochondrial protist lineages it is already clear
that these unrelated anaerobic eukaryotes seem to use convergent
metabolic strategies imposed by their environments. As a first
insight into an amitochondrial protist genome, analysis of these
data and particularly the bacterial-like proteins contained therein
should illuminate future efforts aimed at the development of
diagnostics and therapeutics of these luminal parasites. A
Methods
Genome sequencing and assembly
The E. histolytica genome sequence was generated by the whole-genome shotgun method.
As the chromosomes of E. histolytica could not be resolved by pulsed field gel
electrophoresis (PFGE) and the A þ T content precluded making large or medium insert
libraries in bacterial artificial chromosomes (BACs), we were required to use the whole-
genome shotgun approach to sequence the genome. Genomic DNA was prepared from
E. histolytica strain HM-1:IMSS (ATCC number 30459) grown axenically in TYI-S-33
medium20. At TIGR 390,000 reads were produced from a small (1.5–2.0 kb) and a medium
insert library (8–10 kb) generated in the pHOS2 vector. At the Sanger Institute, 200,000
reads were generated from a pUC18 library with average insert size of 2.5 kb plus 6,500
reads from a BAC library with an average insert size of 10 kb (the high A þ T content of the
genomic DNA prevented cloning of larger fragments). To avoid assembly problems, reads
containing episomal-derived rDNA or tRNA-containing sequences (170,000 reads (29%))
were excluded from the whole-genome assembly process. The average edited read length
was 645 bp, giving an approximate 12.5-fold genome coverage. Genome assembly was
carried out at the Sanger Centre using the program phusion21. All scaffolds smaller than
Figure 2 Predicted signal transduction mechanisms of E. histolytica based on analysis of
the genome sequence data. E. histolytica possesses three types of receptor serine/
threonine kinases: one group has CXXC repeats in the extracellular domain; a second has
CXC repeats; and a third has non-cysteine rich (NCR) repeats. E. histolytica has cytosolic
tyrosine kinases (TyrK), but not receptor tyrosine kinases. Some serine/threonine
phosphatases (S/TP) have an attached LRR domain. CaBP, calcium-binding protein;
DAG, diacylglycerol; G, G protein; GAP, GTPase-activating protein; GEF, guanine
nucleotide exchange factor; IP3, inositol-1,4,5-trisphosphate; PI(3)K,
phosphatidylinositol-3-OH kinase; PIP2, phosphatidylinositol-4,5-bisphosphate; PIP3,
phosphatidylinositol-3,4,5-trisphosphate; PKC, protein kinase C; PLC, phospholipase C;
PTEN, phosphatase and tensin homologue; TyrP, tyrosine phosphatase; 7TM receptors,
seven-transmembrane receptors.
Figure 3 Predicted pathways for oxidative and nitrosative stress resistance in
E. histolytica. Enzymes boxed and shaded have previously only been identified in
anaerobic prokaryotes and amitochondrial protists. a, Superoxide is detoxified by an iron-
containing superoxide dismutase (Fe-SOD). Molecular oxygen is reduced to hydrogen
peroxide by the NADPH-flavin oxidoreductase (p34), which also transfers electrons to
peroxiredoxin (p29). Rubrerythrin (Rbr) is predicted to convert hydrogen peroxide to water,
although the source of electrons for rubrerythrin in E. histolytica is unknown. b, A-type
flavoproteins (FprA) detoxify nitric oxide to nitrous oxide. FprA receives electrons from
flavoprotein A reductase (Far).
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2 kb (327) were subsequently removed, leaving 1,425 scaffolds with a combined size of
25,393,225 bp. The remaining scaffolds were analysed to remove redundancy that may
have resulted as a consequence of allelic differences or aneuploidy. We removed all
scaffolds smaller than 5 kb that shared 98% or more nucleotide sequence identity over
greater than 95% of their lengths. Removal of these scaffolds left 888 scaffolds remaining,
with a total length of 23,751,783 bp. All scaffolds removed during the clean-up process as
well as any singleton reads, although not used in the annotation process, were used in
determining the presence or absence of genes in the E. histolytica genome. Unfortunately,
there is no map to order the scaffolds generated by the assembly; however, the sequence
generated by this project should assist in making maps for this genome in the future, and
although the large-scale structure of the genome has been lost, the vast majority of the
genes that have been predicted are full length with intact 3
0
and 5
0
untranslated regions.
Annotation
The Combiner algorithm was used for gene structure identification22 using two genefinder
programs, phat23 and GlimmerHMM24, trained using a set of published E. histolytica gene
sequences, alignments of protein homologues to the genomic sequence and alignment of a
set of E. histolytica complementary DNA sequences (provided by N. Guille´n) to the
genomic sequence. The Combiner gene predictions were then manually curated.
Functional annotations for the predicted proteins were automatically generated using a
combination of numerous sources of evidence including searches against a non-redundant
protein database and identification of functional domains by searches against the Pfam
database25. tRNAs were detected using the tRNAscan-SE26 program with default parameters.
Identification of sequence homologues in other species
Sequence homologues from other species were identified by searching the predicted
proteins from the E. histolytica genome against the publicly available nr database of
GenBank using BlastP (http://www.ncbi.nlm.nih.gov/BLAST/) and filtering search results
with an e-value of 1025 or less, which was chosen because of the relatively large divergence
between E. histolytica and other organisms for which the genomes have been sequenced
and for which protein data are available.
Phylogenetic analysis
We modified a published suite of scripts and modules called PyPhy27 to make an
automated genome-wide primary screen for LGT. PyPhy was used to make bootstrap (100
replicates) consensus p-distance trees from edited alignments of 5,740 E. histolytica
proteins; that is, those for which there were sufficient homologues (.4) in SwissProt and
TrEMBL to make trees. The trees were analysed to identify cases where the nearest
neighbour to the E. histolytica protein was a prokaryotic sequence. As an additional screen
for LGT we identified all proteins for which a prokaryote was the top Blast hit. After
manual inspection of the alignments, Blast outputs, tree support values and sequence
identities, 279 cases of potential LGT were retained for more detailed phylogenetic
analyses. Each candidate LGTwas analysed by MrBayes28 using the WAG matrix, a gamma
correction for site rate variation and a proportion (pinvar) of invariant sites. The analyses
were run for 600,000 generations and sampled every 100 generations, with the first 2,000
samples discarded as burn-in. A consensus tree was made from the remaining samples.
Because posterior probabilities—the support values used by bayesian analysis to indicate
confidence in groups—have been criticized29, we also used bootstrapping to provide an
additional indication of support for relationships. Each data set was bootstrapped (100
replicates) and used to make distance matrices under the same evolutionary model as in
the bayesian analysis, using custom (P4) software (available on request). Trees were made
from the distance matrices using FastME30 and a bootstrap consensus tree made using P4.
On the basis of these analyses we identified 96 genes in which the tree topology is
consistent with prokaryote to eukaryote LGT. Blast summary statistics, trees and support
values for these 96 candidate LGT are provided as Supplementary Information.
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The specificity of cortical neuron connections creates columns of
functionally similar neurons spanning from the pia to the white
matter1–6. Here we investigate whether there is an additional,
finer level of specificity that creates subnetworks of excitatory
neurons within functional columns. We tested for fine-scale
specificity of connections to cortical layer 2/3 pyramidal neurons
in rat visual cortex by using cross-correlation analyses of synaptic
currents evoked by photostimulation. Recording simultaneously
from adjacent layer 2/3 pyramidal cells, we find that when they
are connected to each other (20% of all recorded pairs) they share
common input from layer 4 and within layer 2/3. When adjacent
layer 2/3 neurons are not connected to each other, they share very
little (if any) common excitatory input from layers 4 and 2/3. In
contrast, all layer 2/3 neurons share common excitatory input
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Abstract The intestinal parasite Entamoeba histolytica is one of the first
protists for which a draft genome sequence has been published.
Although the genome is still incomplete, it is unlikely that many
genes are missing from the list of those already identified. In this
chapter we summarise the features of the genome as they are
currently understood and provide previously unpublished analyses
of many of the genes.
1. INTRODUCTION
Entamoeba histolytica is one of the most widespread and clinically impor-
tant parasites, causing both serious intestinal (amoebic colitis) and extra-
intestinal (amoebic liver abscess) diseases throughout the world. A recent
World Health Organization estimate (WHO, 1998) places E. histolytica
second after Plasmodium falciparum as causing the most deaths annually
(70,000) among protistan parasites.
Recently a draft of the complete genome of E. histolyticawas published
(Loftus et al., 2005) making it one of the first protist genomes to be
sequenced. The E. histolytica genome project was initiated in 2000 with
funding from the Wellcome Trust and the National Institute of Allergy
and Infectious Diseases to the Wellcome Trust Sanger Institute and
The Institute for Genomic Research (TIGR) in the UK and the USA,
respectively. The publication describing the draft sequence concentrated
on the expanded gene families, metabolism and the role of horizontal
gene transfer in the evolution ofE. histolytica. In this chapterwe summarise
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the structure and content of the E. histolytica genome in comparison to
other sequenced parasitic eukaryotes, provide a description of the current
assembly and annotation, place the inferred gene content in the context
of what is known about the biology of the organism and discuss plans
for completing the E. histolytica genome project and extending genome
sequencing to other species of Entamoeba.
The fact that the genome sequence is still a draft has several important
consequences. The first is that a few genes may be missing from the
sequence data we have at present, although the number is likely to
be small. For example, at least one gene (amoebapore B) is not present
in the genome data despite it having been cloned, sequenced and the
protein extensively characterised well before the start of the genome
project. The second consequence is that the assembly contains a number
of large duplicated regions that may be assembly artefacts, meaning that
the number of gene copies is overestimated in several cases. These pro-
blems cannot as yet be resolved but should be eventually as more data
becomes available. Nevertheless, it is important to remember these issues
when reading the rest of this chapter.
As the number of genes in E. histolytica runs into several thousands, it is
not possible to discuss all of them.However, we have generated a number of
tables that identify many genes and link them to their entries in GenBank
using the relevant protein identifier. Only a few tables are included in the
text of this chapter, but the others are available online as supplementary
material, http:/pathema.tigr.org/pathema/entamoeba_resources.shtml. The
E. histolytica genome project data are being ‘curated’ at the J. Craig Venter
Institute ( JCVI, formerly TIGR), and it is on that site that the most current
version of the assembled genomewill be found. The ‘Pathema’ databasewill
hold the data and the annotation (http:/pathema.tigr.org/). The gene tables
are also linked to the appropriate entry in the Pathema database, and the
links will be maintained as the genome structure is refined over time.
Reference is made throughout the text to other species of Entamoeba
where data are available. Entamoeba dispar is the sister species to
E. histolytica and infects humans without causing symptoms. Entamoeba
invadens is a reptilian parasite that causes invasive disease, primarily in
snakes and lizards, and is widely used as a model for E. histolytica in the
study of encystation, although the two species are not very closely related
(Clark et al., 2006b). Genome projects for both these species are under way
at TIGR, and it is anticipated that high-quality draft sequences will
be produced for both in the near future. It is hoped that the E. dispar
sequence will prove useful in identifying genomic differences linked to
disease causation while that of E. invadenswill be used to study patterns of
gene expression during encystation. Small-scale genome surveys have
been performed for two other species: Entamoeba moshkovskii, which
is primarily a free-living species although it occasionally infects humans,
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and Entamoeba terrapinae, a reptilian commensal species, http:/www.
sanger.ac.uk/Projects/Comp_Entamoeba/
2. GENOME STRUCTURE
2.1. The E. histolytica genome sequencing, assembly
and annotation process
The first choice to be made in the genome project was perhaps the
easiest—the identity of the strain to be used for sequencing. A significant
majority of the existing sequence data prior to the genome project was
derived from one strain: HM-1:IMSS. This culture was established in 1967
from a rectal biopsy of a Mexican man with amoebic dysentery and
axenised shortly thereafter. It has been used widely for virulence, immu-
nology, cell biology and biochemistry in addition to genetic studies. In an
attempt to minimise the effects of long-term culture cryopreserved cells
that had been frozen in the early 1970s were revived and this uncloned
culture used to generate the DNA for sequencing.
Before undertaking a genome scale analysis, it is important to under-
stand the quality and provenance of the underlying data. The E. histolytica
genome was sequenced by whole genome shotgun approach with
each centre generating roughly half of the reads. Several different DNA
libraries containing inserts of different sizeswere produced usingDNA that
hadbeen randomly shearedand sequenceswere obtained fromboth ends of
each cloned fragment. The Phusion assembler (Mullikin and Ning, 2003)
was used to assemble the 450,000 short reads into larger contigs (contiguous
sequences), resulting in 1819 genome fragments that were 12 deep,
which means that each base has been sequenced 12 times, on average.
While the genome shotgun sequence provides high coverage of each base,
it is inevitable that there will bemisassemblies and sequencing errors in the
final consensus particularly towards each end of the contigs. Another
problem with draft sequence is that it contains gaps, and while most of
these will be small and will mostly contain repetitive non-coding ‘junk’
sequence, some of the gaps will probably contain genes. This makes it
impossible to be absolutely certain of the absence of particular genes in
E. histolytica and, in some cases, the presence or absence of particular
biological pathways. Due to the high repeat content and low GC content
(24.1%) of the E. histolytica genome, closure of the remaining gaps is likely
to be a lengthy process. Therefore, it was decided to undertake and
publish an analysis of the genome draft following assembly of the shotgun
reads.
Annotation of the protein coding regions of the genome was initially
carried out using two genefinders [GlimmerHMM (Majoros et al., 2004)
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and Phat (Cawley et al., 2001)] previously used successfully on another
low G þ C genome, that of P. falciparum. The software was re-trained
specifically for analysis of the E. histolytica genome. The training process
involved preparing a set of 600 manually edited genes to be used as
models with the subsequent genefinding then being carried out on all of
the assembled contigs to generate a ‘complete’ gene set. Predicted gene
functions were generated automatically by homology searches using
public protein and protein-domain databases, with subsequent refine-
ment of identifications being carried out by manual inspection. For
particular genes and gene families of special interest, members of the
Entamoeba scientific community were involved throughout this process
as expert curators with each individual assisting in the analysis and
annotation of their genes of interest. Therefore although the manual
curation of the genome has not been systematic, those areas of biology
that are of primary interest to the Entamoeba community have been
annotated most thoroughly. The publication of the genome by Loftus
et al. therefore represents a ‘first draft’ of the complete genome sequence
and the level of annotation is similar to the initial publications of other
genomes such as Drosophila (Adams et al., 2000; Myers et al., 2000) and
human (Lander et al., 2001).
2.2. Karyotype and chromosome structure
The current E. histolytica genome assembly is 23.7 million basepairs
(Mbp) in size (Table 2.1). This figure is not likely to be a very accurate
measure. In part this is due to misassembly of repetitive regions, which
will cause the genome to appear smaller and in part because of the
possibility of aneuploidy in some regions of the genome, which would
cause them to appear more than once in the assembly. Overall, however,
this size is not inconsistent with data from pulse-field gels (Willhoeft and
Tannich, 1999) and kinetic experiments (Gelderman et al., 1971a,b)
making the E. histolytica genome comparable in size (24 Mbp) to that of
P. falciparum (23 Mbp) (Gardner et al., 2002), Trypanosoma brucei (26 Mbp)
(Berriman et al., 2005) and the free-living amoeba Dictyostelium discoideum
(34 Mbp) (Eichinger et al., 2005).
The current assembly does not represent complete chromosomes.
Analysis of pulse-field gels predicts 14 chromosomes ranging in sizes
from 0.3 to 2.2 Mbp and possibly a ploidy of 4 (Willhoeft and Tannich,
1999). There is no current information regarding the size and nature of the
centromeres, and there are no contigs that appear to contain likely centro-
meric regions based on comparisons with other organisms. A search for
signature telomeric repeats within the data indicates that these are either
not present in the genome, not present in our contigs, or are diverged
enough to be unidentifiable. However, there is circumstantial evidence
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only 33% sequence identity. At present, the function of the various
flavodoxin-like molecules remains to be determined and deserves to
be investigated fully, particularly as to whether they do indeed have
antioxidant capacity.
4. METABOLISM
Biochemical analysis of E. histolytica metabolism has a long history
(Reeves, 1984), dating back to shortly after the development of culture
media that allowed the generation of substantial numbers of axenic cells.
The genome sequence has confirmed most of the predicted metabolic
pathways shown biochemically to be present or absent in E. histolytica in
the past. As with most parasites, secondary loss of biosynthetic pathways
is a recurring theme. However, a few surprises have also been uncovered.
Every single enzyme involved in metabolism cannot realistically be
discussed in this chapter. In this section, only the major energy generating
and biosynthetic aspects of metabolism will be covered. Enzyme names,
EC numbers and accession numbers are given in the the supplementary
table for this section.
4.1. Energy metabolism
4.1.1. Glycolysis
E. histolytica lacks a functional tricarboxylic acid (TCA) cycle and oxidative
phosphorylation. It is not able to convert organic substrates such as
glucose into H2O and CO2, but has to rely on the energy generated by
various types of substrate level phosphorylation (Reeves, 1984). Glycoly-
sis is the major pathway of ATP generation, but in addition the genome
project has identified a number of genes that could result in more ATP
generation through the catabolism of amino acids. These enzymes will
be described further below. As E. histolytica lacks compartmentalised
energy generation, it has been classified as a type I amitochondriate
protist (Martin and Mu¨ller, 1998) in contrast to the type II amitochondri-
ate protists containing hydrogenosomes such as T. vaginalis. Nevertheless,
it does contain a mitochondrial remnant, the mitosome (see Section 8).
In E. histolytica, glycolysis appears to be localised in the cytosol.
This is in contrast to trypanosomes in which a major part is carried out
in the glycosomes (Parsons, 2004) and the pathway is regarded as a
potential target for chemotherapy (Opperdoes and Michels, 2001). The
kinetic properties of recombinant E. histolytica glycolysis enzymes
have recently been studied by Saavedra et al. (2005). Their analysis sug-
gested that fructose-1,6-bisphosphate aldolase, phosphoglycerate mutase,
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glyceraldehyde-3-phosphate dehydrogenase and pyruvate phosphate
dikinase might be regulating the glycolytic flux.
4.1.1.1. Hexokinases Glucose taken up by E. histolytica is phosphorylated
by two hexokinase (EC 2.7.1.1) isoenzymes (Hxk1 and Hxk2). The two
E. dispar isoenzymes are shifted towards a slightly more basic pI, which is
the basis of the classical biochemicalmethod for distinguishing E. histolytica
from E. dispar by starch gel electrophoresis (Farri et al., 1980). The pI
differences among the two E. histolytica isoforms (Ortner et al., 1995) and
between the two species (Ortner et al., 1997b) are the result of genetic
differences that lead to different amino acid sequences and charge differ-
ences. Hxk1 phosphorylates glucose and mannose, while Hxk2 phosphor-
ylates mainly glucose and is much less active with mannose as a substrate
(Kroschewski et al., 2000).
4.1.1.2. Glucose-6-phosphate isomerase Glucose 6-phosphate is converted
to fructose 6-phosphate by glucose-6-phosphate isomerase (EC 5.3.1.9).
The genome has two genes for this enzyme, which code for proteins that
differ only by a single insertion or deletion of seven amino acid residues.
Glucose-6-phosphate isomerase is another of the enzymes for the classical
differentiation of Entamoeba zymodemes by starch gel electrophoresis
(Sargeaunt, 1987).
4.1.1.3. Phosphofructokinases The main phosphofructokinase activity in
E. histolytica is pyrophosphate (PPi)-dependent (EC 2.7.1.90; Reeves et al.,
1976). There is a single gene (Deng et al., 1998) encoding this 60 kDa
enzyme. The gene is a candidate for lateral transfer from bacteria
(Loftus et al., 2005) (see Section 10). The enzyme is expressed at a 10-fold
higher level and displays about 10-fold higher activity than a second
phosphofructokinase of 48 kDa (XP_653373) (Chi et al., 2001). The sub-
strate specificity of the smaller enzyme is disputed. Whereas Bruchhaus
et al. (1996) reported that this minor enzyme also used PPi as phosphate
donor, Chi et al. (2001) found only an ATP-dependent activity. The 48 and
60 kDa enzymes are highly divergent with<20% sequence identity. Inter-
estingly, the specificity of the 60 kDa phosphofructokinase can be
changed from PPi to ATP by mutation of a single amino acid residue
(Chi and Kemp, 2000). The authors concluded that ATP rather than PPi
was the primordial high energy compound. In the genome, there are
2 additional genes encoding isoforms of the 48 kDa enzyme, which have
not been studied at the protein level.
4.1.1.4. Fructose-1,6-bisphosphate aldolase Fructose 1,6-bisphosphate is
cleaved to glyceraldehyde 3-phosphate and dihydroxyacetone 3-phosphate
by fructose-1,6-bisphosphate aldolase (EC 4.1.2.13). The enzyme, a class II
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aldolase (Marsh and Lebherz, 1992), has been cloned (XP_650373) and
exhibits strong sequence similarity to eubacterial aldolases (Sanchez et al.,
2002). A second gene (XP_655966) encodes a protein differing from the first
by a single deletion of 28 amino acids flanked by short divergent stretches.
These bacterial-type aldolases are also found in T. vaginalis, G. intestinalis
and other protists (Sanchez et al., 2002). E. histolytica has no gene coding for
a class I aldolase like those found in animals, whichmightmake aldolase an
interesting target for chemotherapy.
4.1.1.5. Triose-phosphate isomerase Triose-phosphate isomerase (EC
5.3.1.1) converts dihydroxyacetone 3-phosphate into glyceraldehyde
3-phosphate. The gene was previously cloned (Landa et al., 1997), and is
highly similar to the annotated gene product. This dimer-forming enzyme
represents the first E. histolytica protein for which the structure has been
solved by X-ray crystallography (Rodriguez-Romero et al., 2002).
4.1.1.6. Glyceraldehyde-3-phosphate dehydrogenase Glyceraldehyde-3-
phosphate dehydrogenase (EC 1.2.1.12) oxidises and phosphorylates
glyceraldehyde 3-phosphate to 1,3-bisphosphoglycerate in two coupled
reactions using NADþ as cofactor (Reeves, 1984). The genome project
revealed 5 putative genes, 3 of which encode the identical protein
sequence of 36.0 kDa and a predicted pI of 7.04. The fourth gene product,
XP_648981, differs from these 3 only by a 13 amino acid deletion, while
XP_650370 is a clearly distinct 34.8 kDa isoform with a lower predicted pI
of 5.80. Interestingly, the isoforms XP_650356 and XP_650370 of different
pI are encoded within the same contig.
4.1.1.7. Phosphoglycerate kinase Phosphoglycerate kinase has an unusual
substrate (Reeves and South, 1974), transferring the high energy phos-
phate group from 3-phosphoglyceroyl phosphate to GDP leading to the
formation of GTP (EC 2.7.2.10). There is one candidate gene encoding a
45 kDa protein.
4.1.1.8. Phosphoglyceratemutase Phosphoglyceratemutase(Reeves,1984)
isomerises 3-phosphoglycerate to 2-phosphoglycerate (EC 5.4.2.1). Five
divergent putative genes for this enzyme are found in the genome. Two
gene products of 62 kDa were classified as 2,3-bisphosphoglycerate-
independent phosphoglycerate mutases (XP_649031 and XP_654182);
they differ only at their C-termini and display significant similarity to
bacterial phosphoglycerate mutases. The three other genes are very diver-
gent. XP_651808 was identified as a candidate for lateral gene transfer
(LGT) (Loftus et al., 2005) (see Section 10). The remaining two gene
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products XP_649053 and XP_657284 are related to genes found in both
prokaryotes and eukaryotes.
4.1.1.9. Enolase (2-phosphoglycerate dehydratase) Enolase (EC 4.2.1.11)
converts 2-phosphoglycerate to phosphoenolpyruvate. The gene has
been cloned (Beanan and Bailey, 1995) and the protein characterised
(Hidalgo et al., 1997) previously. The 47 kDa gene product is a typical euk-
aryotic enolase (XP_649161). A carboxy-terminally truncated incomplete
ORF is also found.
4.1.1.10. Pyruvate, orthophosphate dikinase and pyruvate kinase In
E. histolytica, both activities forming ATP and pyruvate from phospho-
enolpyruvate have been found. The exergonic pyruvate kinase reaction
uses ADP (Saavedra et al., 2004), and the pyruvate, orthophosphate diki-
nase uses AMP and PPi in a slightly endergonic reaction (Varela-Gomez
et al., 2004). The dikinase activity is found in C4 plants where it is involved
in phosphoenolpyruvate generation for gluconeogenesis. In E. histolytica
it was discovered long before the pyruvate kinase (Reeves, 1968).
The cloning of pyruvate, orthophosphate dikinase (EC 2.7.9.1) was
reported by two groups. The published sequences (Bruchhaus and
Tannich, 1993; Saavedra Lira et al., 1992) are highly similar or identical
to XP_657332 and XP_654666. In addition there are two shorter related
ORFs.
In the genome three putative pyruvate kinase genes (EC 2.7.1.40) have
been identified. The three are identical except for an amino-terminal
deletion in XP_648240 and an internal deletion in XP_653635.
4.1.1.11. Pyruvate:ferredoxin oxidoreductase (PFOR) and ferredoxin PFOR
(EC 1.2.7.1) is an enzyme of major importance to E. histolytica, as the
parasite lacks NADþ-dependent pyruvate dehydrogenase and pyruvate
decarboxylase (Reeves, 1984). No evidence for the latter two genes
was found in the genome, confirming the biochemical results. PFOR
oxidatively decarboxylates pyruvate to acetyl-CoA. The electrons are
transferred to ferredoxin which, in its reduced form, can activate and
reduce metronidazole, the major anti-amoebic drug (Mu¨ller, 1986). The
activated form of metronidazole can potentially react with a number of
biomolecules and is able to cleave the parasite DNA. In human cells,
metronidazole is not activated and is much less toxic. In T. vaginalis,
down-regulation of PFOR is one mechanism of producing metronidazole
resistance (Kulda, 1999); however, PFOR expression appears unaltered in
partially resistant E. histolytica (Samarawickrema et al., 1997; Wassmann
et al., 1999). All eukaryotic PFOR genes, including that of E. histolytica,
appear to have been acquired during an ancient LGT event from bacteria
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(Horner et al., 1999; Rotte et al., 2001). There are two putative PFORs in the
E. histolytica genome, displaying minor sequence differences.
The genome contains seven ferredoxin genes in total with five quite
divergent sequences. All are related to eubacterial and archaeal ferred-
oxins (Nixon et al., 2002). The gene pairs XP_655183/XP_655182 and
XP_654311/XP_652694 are identical. The other three gene products
represent more divergent ORFs. The deduced proteins have similar
molecular masses, between 6.1 and 8.8 kDa, and different predicted
isoelectric points between 4.2 and 8.6 kDa.
4.1.1.12. Acetyl-CoA synthetase (acetate thiokinase) The normal fate of
acetyl-CoA in mitochondriate organisms is entry into the tricarboxylic
acid cycle. However, this pathway is absent from E. histolytica. Instead,
the cleavage energy of the thioester bond of acetyl-CoA can be used
to generate one ATP molecule. One of the known acetyl-CoA synthetases
generates ATP from ADP and Pi (EC 6.2.1.13). Such an enzyme has been
characterised by Reeves et al. (1977) and cloned (Field et al., 2000), and
reported to be a 77 kDa protein. The common acetyl-CoA synthetase
activity that produces ATP from AMP and PPi (EC 6.2.1.1) appears to be
absent in E. histolytica.
4.1.1.13. Aldehyde and alcohol dehydrogenases The E. histolytica genome
encodes a complex system of alcohol or aldehyde dehydrogenases.
In total, there are 25 predicted genes, 3 of which are on the list of LGT
candidates.
Alcohol dehydrogenase ADH1 was the first alcohol dehydrogenase to
be characterised in E. histolytica (Reeves et al., 1971) and is a NADPH-
dependent enzyme (EC 1.1.1.2). The gene was previously cloned (Kumar
et al., 1992); in the genome 3 genes are almost identical to that sequence,
while 1 (XP_652772) has 67% identity.
Fermentation in E. histolytica uses the bifunctional NADH-dependent
enzyme ADH2, which belongs to the ADHE family and has both alcohol
dehydrogenase and aldehyde dehydrogenase activities (Lo and Reeves,
1978). Under anaerobic conditions, reduction of the acetyl-CoA generated
by PFOR to ethanol is one way to regenerate the NADþ used by glyceral-
dehyde-3-phosphate dehydrogenase. ADH2 first reduces acetyl-CoA to
an enzyme-bound hemiacetal which is then hydrolysed to acetaldehyde
(EC 1.2.1.10) and further reduced to ethanol (EC 1.1.1.1). If the enzyme is
also able to work in the reverse direction, E. histolytica would be able to
generate acetyl-CoA and energy from ethanol in the presence of oxygen.
This would explain older reports of ethanol stimulated oxygen uptake in
E. histolytica (Weinbach andDiamond, 1974). The enzyme is closely related
to AdhE from E. coli and other bacteria (Reid and Fewson, 1994), and
there is strong support for its aquisition by LGT (Andersson et al., 2006;
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Field et al., 2000; Loftus et al., 2005) (see Section 10). Like its bacterial
homologue, ADH2 appears to form helical rods that sediment with mem-
brane fractions (Avila et al., 2002). Two groups have previously cloned
ADH2 (Bruchhaus and Tannich, 1994; Yang et al., 1994), and in total the
genome contains five full-length ADH2 genes and one that is truncated.
All share between 98 and 100% sequence identity.
In total, there are 11 alcohol dehydrogenase ADH3 genes in the genome,
2 of which have been reported previously (Kimura et al., 1996; Rodriguez
et al., 1996). The recombinant enzyme characterised by Rodriguez et al.
(1996) was NADPH-specific, like ADH1. There are five genes similar to
these previously reported sequences. The rest of the ADH3 sequences fall
into two groups of three similar sequences. All 11 ADH3 sequences are
between 44 and 100% identical on the amino acid level. XP_649823 was
originally on the list of LGT candidates (Loftus et al., 2005), and a similarity
to ADH3 sequences of gram-negative bacteria had been noted before
(Nixon et al., 2002). However, a related sequence is now known to exist in
T. vaginalis also (see Section 10).
The genome encodes three additional distinct alcohol dehydro-
genases. XP_656535 is a putative Zn-containing enzyme, and is on the
list of LGT candidates. XP_652753 has been annotated as a Fe-containing
alcohol dehydrogenase and XP_652262 simply as putative alcohol
dehydrogenase.
One NADPH-dependent aldehyde dehydrogenase encoding gene
(ALDH1) is present and was reported previously (Zhang et al., 1994).
4.1.2. Energy storage: The glycogen metabolism
E. histolytica uses glycogen as its major energy store. Glycogen is a
polymer of a-1,4-linked glucose chains with a-1,6 branch points, which
in E. histolytica has a compact structure as suggested by branch points
every 5–6 glucose residues (Bakker-Grunwald et al., 1995). The cytoplasm
of trophozoites contains numerous glycogen granules that were first
observed by electron microscopy (Rosenbaum and Wittner, 1970) and
later characterised biochemically (Takeuchi et al., 1977). A glycogen phos-
phorylase activity (EC 2.4.1.1), associated with the glycogen granules,
generates glucose 1-phosphate from orthophosphate and the linear por-
tion of various glucopolysaccharides (Werries and Thurn, 1989). The
genome contains at least six putative full-length and truncated genes
encoding glycogen phosphorylases, two of which were cloned by Wu
and Mu¨ller (2003). These authors noted a marked sequence divergence
in those regions of the enzymes involved in regulation by phosphoryla-
tion and concluded that classical regulation by phosphorylation may not
occur.
Glycogen phosphorylase degrades the linear chains only down to the
a-1,6 branch points. The remaining core molecule is called limit dextrin.
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Degradation can proceed further with the help of a debranching enzyme
that has been purified (Werries et al., 1990). It exhibits activities of
both amylo-1,6-glucosidase (EC 3.2.1.33) and 4-a-glucanotransferase (EC
2.4.1.25). The genome contains two genes putatively encoding a full-length
(XP_653608) and a truncated glycogen debranching enzyme. The deduced
molecular mass of the large protein is 166 kDa, which corresponds to the
biochemical data (Werries et al., 1990).
Glucose 1-phosphate is isomerised to glucose 6-phosphate by phos-
phoglucomutase (EC 5.4.2.2) before entering the glycolytic pathway. The
isoelectric points of the phosphoglucomutases from E. histolytica and
E. dispar differ, and this was exploited for differentiation of the two
species by starch gel electrophoresis (Sargeaunt et al., 1978). Themigration
properties are reproduced by recombinant enzymes and are the result of
primary sequence differences (Ortner et al., 1997a). E. histolytica has one
gene coding for this important enzyme, and in addition there are two
distantly related members of the phosphoglucomutase/phosphomanno-
mutase family.
Genes encoding the enzymes involved in glycogen biosynthesis in
E. histolytica have been identified: a glycogen synthase (EC 2.4.1.11) of
155 kDa and 2 putative branching enzymes (EC 2.4.1.18). The glycogen
precursor UDP-glucose is generated from UTP and glucose 1-phosphate
by UTP:glucose-1-phosphate uridylyltransferase (EC 2.7.7.9). Two UTP-
hexose-1-phosphate uridyltransferases have been characterised biochem-
ically, a larger glucose 1-phosphate-specific enzyme of 45 kDa and a less
specific enzyme of 40 kDa reported to use both galactose 1-phosphate and
glucose 1-phosphate (Lobelle-Rich and Reeves, 1983). The genome con-
tains one larger ORF encoding a putative UTP:glucose-1-phosphate uri-
dylyltransferase of 54.7 kDa and 2 smaller ones encoding enzymes of
46.3 kDa with high similarity identified as UTP:N-acetyl-glucosamine-1-
phosphate uridyltransferases. These enzymes are interesting in that they
could possibly be involved in the activation of N-acetyl-glucosamine
1-phosphate as a precursor of the chitin cyst wall.
4.1.3. Catabolism of sugars other than glucose
4.1.3.1. Activation of fructose and galactose for glycolysis Neither Hxk1
nor Hxk2 can use fructose or galactose as a substrate, but there are 2 genes
encoding bacterial-type enzymes that may do so, a 33 kDa fructokinase,
which is one of the candidates for LGT to the E. histolytica lineage (see
Section 10), and a 43 kDa galactokinase. The fructokinase groups with
bacterial fructose 6-kinases (EC 2.7.1.4), and the galactokinase groups with
galactose 1-kinases (EC 2.7.1.6). This substrate specificity has been noted
before (Reeves, 1984). Fructose 6-phosphate enters as an intermediate of
the glycolytic pathway (see Section 4.1.1.3). As described earlier (see Section
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4.1.2), galactose 1-phosphate can be activated to UDP-galactose (Lobelle-
Rich and Reeves, 1983) and then epimerised to UDP-glucose by UDP-
glucose 4-epimerase (EC 5.1.3.2) (Reeves, 1984). In the genome, a single
candidate 38 kDa ORF for the latter enzyme has been identified. The UDP-
bound glucose can then be used either for the synthesis of glycogen or
fed into the glycolysis pathway via glucose 1-phosphate and glucose
6-phosphate.This efficientpathwayallowsE. histolytica togrowongalactose
instead of glucose (Reeves, 1984).
4.1.3.2. Anomerisation of aldoses The 1-position in the pyranose form of
aldoses has a hydroxyl group that can be in either the a- or b-configuration.
These forms can be interconverted by means of an aldose 1-epimerase
(EC 5.1.3.3), an enzyme that has recently been characterised (Villalobo
et al., 2005). There is a single gene encoding this product.
4.1.3.3. Activation of pentoses Two gene candidates encoding pentose-
activating enzymes have been identified in the E. histolytica genome: a
35 kDa ribokinase (EC 2.7.1.15) and a 56 kDa xylulokinase (EC 2.7.1.17).
The latter is another bacterial-type sequence putatively acquired by LGT.
4.1.3.4. Interconversion of hexoses and pentoses The pathway of intercon-
version between hexoses and pentoses inE. histolyticawas describedmany
years ago (Reeves, 1984; Susskind et al., 1982). A transketolase (EC 2.2.1.1)
converts fructose 6-phosphate and glyceraldehyde 3-phosphate into xylu-
lose 5-phosphate and erythrose 4-phosphate. Erythrose 4-phosphate and
dihydroxyacetone phosphate are condensed by the glycolytic enzyme
fructose-1,6-bisphosphate aldolase to sedoheptulose 1,7-bisphosphate, an
extended substrate specificity of the aldolase. Phosphofructokinase then is
able to remove a phosphate group forming diphosphate and sedoheptulose
7-phosphate. This molecule and glyceraldehyde 3-phosphate are then
converted by transketolase to the pentoses ribose 5-phosphate and xylulose
5-phosphate. A transaldolase activity is absent (Reeves, 1984) consistent
with there being no such gene in the genome. In contrast, 7 gene products
were identified as likely transketolases: 3 highly similar proteins of 73 kDa
and 4 truncated versions.
4.2. Amino acid catabolism
4.2.1. General features
As discussed earlier, glycolysis under anaerobic conditions can use only
part of the energy contained in glucose for ATP generation. E. histolytica is
capable not only of taking up amino acids (Reeves, 1984), but also using
them for the generation of energy, as suggested by Zuo and Coombs (1995).
The genome has revealed a number of unusual genes, often with bacterial
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affinities, coding for enzymes of amino acid catabolism (Anderson and
Loftus, 2005).
In many cases, the degradation of amino acids starts with a transami-
nation reaction (EC 2.6.1.-) generating a 2-ketoacid. The E. histolytica
genome has five ORFs identified as aminotransferases. These ORFs are
distinct from each other with the exception of XP_655090 and XP_655099,
which differ only by one insertion and are LGT candidates. So far there is
no enzymological data on this group of enzymes, so their substrate
specificities in E. histolytica are unknown.
Both amino acid degradation and glycolysis have 2-ketoacids as inter-
mediates. Pyruvate is one common intermediate, as amino acid degrada-
tion can produce either pyruvate or other 2-ketoacids. PFOR (see Section
4.1.1.11) is known to have a relaxed specificity, and in addition to pyru-
vate it can oxidatively decarboxylate 2-ketobutanoate, oxaloacetate and
2-ketoglutarate (Samarawickrema et al., 1997). The reaction generates
CoA-thioesters with the potential of producing one ATP per molecule.
The amino acids asparagine, aspartate, serine, alanine, tryptophan,
cysteine, threonine, methionine, glutamine and glutamate can all be
transformed into one of these 2-ketoacids in one or very few steps. This
underlines the major importance of the PFOR in the energy metabolism of
E. histolytica. The enzyme is indispensable, and as it always generates
reduced ferredoxin it will always activate metronidazole. Consequently,
it would be very difficult for E. histolytica to become resistant to
metronidazole.
4.2.1. Aspartate and asparagine
E. histolytica takes up asparagine and aspartate in the presence or absence of
glucose (Zuo and Coombs, 1995). Four putative asparaginases (EC 3.5.1.1)
are found in the genome. Three are identical and share only 48% amino
acid identity with the fourth (XP_656586). Asparaginase mediates the
formation of aspartate from aspargine by releasing ammonia. The pre-
dicted sequences appear to possess a signal sequence, as suggested
by the TargetP programme (http://www.cbs.dtu.dk/services/TargetP/),
which is reminiscent of a periplasmic isotype (EcA, type II) (Swain et al.,
1993) that is up-regulated under anaerobic and carbon-restricted
conditions (Cedar and Schwartz, 1967).
Aspartate can be converted to fumarate and ammonia by aspartate
ammonia-lyase (aspartase, EC 4.3.1.1). Addition of a water molecule
by fumarase (EC 4.2.1.2) produces malate. The genome encodes a putative
fumarase that is related to bacterial class I fumarases. The aspartase is
a member of the bacterial class II fumarase/aspartase protein family
(Woods et al., 1988), and also on the list of LGT candidates.
Aspartate is also decomposed into oxaloacetate and ammonia
by aspartate aminotransferase, with the concomitant production of
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glutamate from 2-oxoglutarate. Oxaloacetate is then converted into
malate via malate dehydrogenase (EC 1.1.1.37) and, since E. histolytica
lacks both a functional TCA cycle and a phosphoenolpyruvate carboxy-
kinase, the malate generated can be decarboxylated oxidatively to pyru-
vate by malic enzyme (EC 1.1.1.39). Both of these enzymes are present in
E. histolytica. Two very similar genes have been identified as encoding
malic enzyme and are LGT candidates.
4.2.2. Serine, threonine
Serine and threonine are also taken up by E. histolytica in the presence
and absence of glucose (Zuo and Coombs, 1995). Serine can be deami-
nated by the pyridoxal phosphate-dependent serine dehydratase (L-ser-
ine ammonia-lyase, EC 4.3.1.17) to pyruvate and ammonia. The enzyme
was characterised by Takeuchi et al. (1979) who showed that addition of
serine to the culture medium stimulated oxygen consumption. In an
analogous reaction, threonine dehydratase (threonine ammonia-lyase,
EC 4.3.1.19) breaks down threonine to 2-oxobutanoate. Both ketoacids
can then be oxidised by PFOR to acetyl-CoA or propionyl-CoA. Both
catabolic reactions can be carried out by the same enzyme, as has been
shown in yeast for example (Ramos and Wiame, 1982). In the E. histolytica
genome annotation, four gene products have been annotated as threonine
dehydratases, but none as serine dehydratase. XP_650405 and XP_652480
are identical while XP_655614 and XP_657171 share 95 and 37%
identity with the others, respectively. The exact substrate specificities
of these four putative serine/threonine dehydratases have not been
reported.
Degradation of serine via the non-phosphorylated serine pathway,
by the sequential reactions of L-serine: pyruvate aminotransferase
(EC 2.6.1.51), D-glycerate dehydrogenase (EC 1.1.1.29) and D-glycerate
kinase (EC 2.7.1.31) (Snell, 1986) results in the glycolytic intermediate
3-phosphoglycerate. The genome encodes several putative aminotrans-
ferases (see Section 4.2.1), but it is not yet known if serine is among their
substrates. An unusual bacterial-type NADPH-dependent D-glycerate
dehydrogenase was characterised by Ali et al. (2003), and there are two
genes encoding D-glycerate dehydrogenases, one of which (XP_648124)
is among the weaker LGT candidates (see Section 10). The genome
also contains two genes encoding identical glycerate kinases. The enzyme
has recently been characterised (V. Ali and T. Nozaki, unpublished data).
4.2.3. Methionine, homocysteine and cysteine
Methionine g-lyase (EC 4.4.1.11) decomposes methionine to methanethiol
(mercaptomethane), ammonia and 2-oxobutanoate. In E. histolytica, two
methionine g-lyases, EhMGL1 and EhMGL2, of similar molecular weights
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have been characterised (Tokoro et al., 2003). These two isoenzymes show
marked differences in substrate specificity, isoelectric point, enzymologi-
cal and biochemical parameters (Tokoro et al., 2003). Both enzymes can
also act on other amino acids. In addition to degrading methionine, both
EhMGL1 (pI 6.01) and EhMGL2 (pI 6.63) can convert homocysteine to
hydrogen sulphide, ammonia and 2-oxobutanoate. EhMGL2 also decom-
poses cysteine to hydrogen sulphide, ammonia and pyruvate, whereas
EhMGL1 is only weakly active against cysteine. Decomposition of homo-
cysteine by methionine g-lyase is essential since this parasite lacks the
other known enzymes capable of destroying this toxic amino acid. In
the genome, three ORFs correspond to EhMGL1 and one to EhMGL2.
So far, the only eukaryotes known to possess methionine g-lyases are
E. histolytica and T. vaginalis (Lockwood and Coombs, 1991). As the
enzymes are absent from the human host and important for the genera-
tion of metabolic energy, they could be targets for chemotherapy (Coombs
and Mottram, 2001; Tokoro et al., 2003).
In addition to serving as a source of metabolic energy, another
important role of methionine is as a donor of methyl groups via S-adeno-
sylmethionine synthetase (synonymous with methionine adenosyltrans-
ferase, EC 2.5.1.6). Seven gene candidates were identified, four full-length
and three truncated. The S-adenosylhomoserine left after the transfer of the
activated methyl group can be hydrolysed by S-adenosylhomocysteine
hydrolase (EC 3.3.1.1), giving adenosine and homocysteine. Two candi-
date genes with identical sequences and one truncated form are present.
However, E. histolytica lacks the remaining enzymes for the reverse
transsulphuration pathway (forming cysteine from methionine) (Nozaki
et al., 2005), that is cystathionine b-synthase and cystathionine g-lyase. In
addition, E. histolytica lacks all enzymes involved in the forward transsul-
phuration (forming methionine from cysteine) including cobalamin-
dependent methionine synthase (EC 2.1.1.13) or cobalamin-independent
methionine synthase (EC 2.1.1.14), which suggests that E. histolytica is
capable of neither converting homocysteine to cystathionine nor recycling
homocysteine to methionine.
E. histolytica lacks the methylthioadenosine cycle enzymes except
for two, 50-methylthioadenosine/S-adenosyl homocysteine nucleosidase
(EC3.2.2.9) andaspartate aminotransferase (AT,EC2.6.1.1).The significance
of these two enzymes in E. histolytica is unknown.
4.2.4. Arginine
In G. intestinalis and T. vaginalis the arginine deiminase (EC 3.5.3.6) path-
way is important for energy generation (Knodler et al., 1994; Linstead and
Cranshaw, 1983; Schofield and Edwards, 1994), generating one ATP
molecule from the breakdown of arginine to ornithine. In contrast, no
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arginine deiminase gene or dihydrolase pathway was detected in the
E. histolytica genome.
In E. histolytica, arginine can either be degraded by arginase
(EC 3.5.3.1) via ornithine or by arginine decarboxylase (EC 4.1.1.19) via
agmatine. The arginine decarboxylase reaction uses up protons and may
be involved in the acid resistance needed for the passage of cysts through
the human stomach (Anderson and Loftus, 2005). Another function
suggested for arginine degradation was that it depletes arginine as a
substrate for human macrophages, preventing NO synthesis and amoe-
bicidal activity (Elnekave et al., 2003). Both enzymes could also be impor-
tant for the generation of the polyamine putrescine (see Section 4.3). The
genome contains a single gene encoding a 96 kDa polypeptide annotated
as ornithine/arginine/lysine decarboxylase, the substrate specificity of
which has not yet been examined on the recombinant protein level.
There is a single gene encoding a putative 33 kDa arginase.
4.2.5. Glutamate, glutamine
In aerobic organisms, the 2-oxoglutarate generated from glutamate in a
transaminase reaction enters the citric acid cycle for further catabolism. In
E. histolytica, which also contains transaminases, 2-oxoglutarate can be
oxidised by PFOR to give succinyl-CoA from which one molecule of ATP
can be generated.
Several other gene products of E. histolytica could act on glutamine and
glutamate. The genome lacks a glutaminase (EC 3.5.1.2) to carry out the
simple hydrolysis of glutamine. Instead there is a putative glucosamine-
fructose-6-phosphate aminotransferase (EC 2.6.1.16), which uses the energy
in the amide group of glutamine to generate glucosamine 6-phosphate
from fructose 6-phosphate. This product may be used for cyst wall
biosynthesis.
4.2.6. Tryptophan
Tryptophan can be degraded to indole, pyruvate and ammonia by the
PLP-dependent enzyme tryptophanase (EC 4.1.99.1), for which one
candidate gene exists. To date, tryptophanase has only been found in
bacteria and T. vaginalis and it is also on the list of LGT candidates.
4.2.7. Alanine: A possible special case
Alanine could potentially be transformed into pyruvate by alanine ami-
notransferase (synonymous with alanine:pyruvate transaminase, EC
2.6.1.2). However, E. histolytica is reported to excrete alanine (Zuo and
Coombs, 1995), suggesting that this enzyme is not used under the culture
conditions tested. Conceivably, the purpose of the excretion process may
be to carry excess nitrogen out of the cell in the absence of a functional
urea cycle.
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4.2.8. Catabolism of other amino acids
Most of the enzymes for branched-chain amino acid metabolism are
missing in E. histolytica, but leucine, isoleucine and valine could be trans-
formed into 2-oxoisocaproate, 2-oxo-3-methylvalerate and 2-oxovalerate,
respectively, byaputativebranched-chain aminoacidaminotransferase (EC
2.6.1.42), one of the aminotransferases mentioned earlier (see Section 4.2).
This could produce ammonia or transfer the amino group to 2-oxoglutarate
to formglutamate. Subsequent oxidativedecarboxylation to give the respec-
tive CoA-derivatives could be envisaged, but so far no gene candidates for
the necessary dehydrogenases have been identified.
One gene encodes a putative histidine ammonia-lyase (EC 4.3.1.3),
which is responsible for the decomposition of histidine into urocanate
and ammonia. Other than the formation of ammonia, the significance of
this enzyme is not clear since the downstream enzymes involved in
histidine catabolism from urocanate to glutamate were not found.
Currently, there is little information regarding the fate of the amino
acids glycine, proline, phenylalanine, tyrosine and lysine in E. histolytica.
No genes for the catabolic enzymes necessary were detected except
for an LGT candidate bacterial-type 96 kDa broad-specificity ornithine/
arginine/lysine decarboxylase that may be acting on lysine.
4.3. Polyamine metabolism
The absence of S-adenosyl-L-methionine decarboxylase (EC 4.1.1.50),
which converts S-adenosyl methionine into decarboxylated S-adenosyl
methionine, spermidine synthase (EC 2.5.1.16) and spermine synthase
(EC 2.5.1.22), suggests a complete lack of polyamine metabolism in this
parasite (Anderson and Loftus, 2005). However, as mentioned earlier,
E. histolytica possesses genes encoding arginase and arginine decarboxyl-
ase. Both could be involved in the production of putrescine via agmatine
and agmatinase (EC 3.5.3.11) or via ornithine and ornithine decarboxylase
(EC 4.1.1.17). The high putrescine concentration in trophozoites demon-
strated by NMR spectroscopy (9.5 mM) (Bakker-Grunwald et al., 1995)
reinforces the physiological significance of putrescine. However, the fate
of putrescine is unknown as neither spermine nor spermidine has been
demonstrated in E. histolytica.
There is controversy regarding the presence or absence of trypa-
nothione, a spermidine-containing thiol, in E. histolytica. Trypanothione is
a major thiol in trypanosomes and leishmania (Fairlamb and Cerami, 1992)
and contains two molecules of glutathione joined by a spermidine linker.
The first reports detected the presence of trypanothione in E. histolytica
(Ondarza et al., 1997) but were contradicted soon after (Ariyanayagam
and Fairlamb, 1999). More recently another study reaffirmed its presence
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(Ondarza et al., 2005). However, the gene encoding trypanothione reduc-
tase reported from E. histolytica strain HK-9 (AF503571) has no homologue
in the genome of HM-1:IMSS. Although this matter has not been resolved,
there is general agreement that the major thiol in E. histolytica is cysteine
(Fahey et al., 1984).
The E. histolytica genome encodes a 46 kDa ornithine decarboxylase
with similarity to both plant and vertebrate enzymes, and there is also the
96 kDa ornithine/arginine/lysine decarboxylase (see Section 4.2.4). Only
the former enzyme has been characterised at the biochemical level
(Arteaga-Nieto et al., 2002) and has been shown to be insensitive to
difluoromethylornithine (DFMO), as is E. histolytica (Gillin et al., 1984).
The conversion of arginine into putrescine via agmatine, in a reaction
initiated by arginine decarboxylase, is generally present in bacteria and
plants. Although arginine decarboxylase is present in E. histolytica, agma-
tinase (EC 3.5.3.11), which further catalyses conversion of agmatine into
putrescine and urea, appears absent. However, one gene identified as a
33 kDa arginase also shares 21% sequence identity with humanmitochon-
drial agmatinase and therefore its substrates need to be examined on the
biochemical level to see whether the enzyme can act on arginine, agma-
tine, or both. At present, the role of arginine decarboxylase in E. histolytica
is not clear, although as mentioned earlier this enzyme may also be
involved in acid resistance in E. histolytica.
4.4. Biosynthesis of amino acids
4.4.1. Cysteine and serine
One of the areas in which reduction of metabolism is most evident is in
amino acid biosynthesis. Biosynthetic pathways for most amino acids
other than serine and cysteine (Ali et al., 2003, 2004a; Nozaki et al.,
1998a, 1999) have been lost in E. histolytica. Similarly, P. falciparum,
which predominantly acquires amino acids from host haemoglobins,
lacks biosynthesis of most amino acids (Gardner et al., 2002). Intracellular
concentrations of some amino acids (glutamate, leucine, valine and pro-
line in descending order of abundance) are very high in E. histolytica
ranging from 6 to 21 mM (Bakker-Grunwald et al., 1995). In particular,
the glutamate and proline concentrations are much higher in the cells
than in the growth medium (21 and 7.3 mM vs. 5.9 and 1.8 mM, respec-
tively). Glutamate accounts for over one-third of the total amino acid pool
(Bakker-Grunwald et al., 1995), and is likely to play a central role in
homeostasis not only of amino acids but also of energy metabolism in
general. Thus, it is likely that these amino acids are actively taken up by
as-yet unidentified amino acid transporters.
Retention of the serine and cysteine biosynthetic pathways when the
others have been lost is likely related to the physiological importance of
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cysteine, which is the major intracellular thiol of this parasite. The cyste-
ine biosynthetic pathway consists of two major steps, catalysed by serine
acetyltransferase (EC 2.3.1.30), which produces O-acetylserine from ser-
ine and acetyl-coenzyme A, and cysteine synthase (EC 2.5.1.47), which
subsequently transfers an alanyl moiety from O-acetylserine to
sulphide to produce cysteine. E. histolytica possesses three genes each
for cysteine synthase and serine acetyltransferase. Cysteine synthases 1
and 2 were considered to be allelic isotypes (Nozaki et al., 1998b), while
cysteine synthase 3 appears to be distinct, with only 83% identity
to cysteine synthases 1 and 2. In contrast, all three serine acetyltransferase
genes seem to be distinct, showing only 48–73% identity (V. Ali and
T. Nozaki., unpublished data). It was previously shown that cysteine
synthases 1 and 2 and serine acetyltransferase 1 are unique in that
(a) they do not form a heterocomplex, in contrast to other organisms
(Bogdanova and Hell, 1997; Droux et al., 1998) and (b) serine acetyltrans-
ferase 1 is sensitive to allosteric inhibition by both L-cysteine and L-cystine
(Nozaki et al., 1999). Since all variants of these two enzymes lack
organelle-targeting sequences, the significance of the multiple isotypes
is unknown. It is important to determine subcellular distribution and
specific functions of these isotypes to understand the significance of the
redundancy. As this pathway is absent in humans, it is a rational target
for development of new chemotherapeutic drugs against amoebiasis.
Serine is synthesised de novo utilising the glycolytic intermediate
3-phosphoglycerate, in a pathway that includes three sequential reactions
catalysed by D-phosphoglycerate dehydrogenase (EC 1.1.1.95), phospho-L-
serine aminotransferase (EC 2.6.1.52), andO-phospho L-serine phosphatase
(EC 3.1.3.3). Although the final enzyme has not yet been enzymologically
and functionally analysed, the first two enzymes have been characterised
(Ali and Nozaki, 2006; Ali et al., 2004a).
4.4.2. Interconversion of glutamate–glutamine and
aspartate–asparagine
The single step interconversions of glutamate and glutamine, catalysed by
glutamate synthase (EC 1.4.1.13) and glutamine synthetase (EC 6.3.1.2),
and of aspartate and asparagine by asparagine synthase (EC 6.3.5.4) are
found in E. histolytica. There are two isotypes of glutamine synthetase with
47% amino acid identity and five candidate genes. NADPH-dependent
glutamate synthase (EC 1.4.1.13) catalyses the formation of two gluta-
mates from glutamine and 2-oxo-glutarate in bacteria, yeasts and plants,
and together with glutamine synthetase is involved in ammonia fixation
under ammonia-restricted conditions. NADPH-dependent glutamate
synthase is normally composed of two large and two small subunits
(Petoukhov et al., 2003). Although three genes encoding the small subunit
are present, the large subunit appears to be absent in E. histolytica. These
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putative NADPH-dependent glutamate synthase small subunits share 80%
amino acid identity and show 44% amino acid identity to homologues from
the Archaea. The similarity to archaeal-type glutamate synthase (Nesbo
et al., 2001) suggests that the E. histolytica small subunits may function as a
glutamate synthase without the large subunit, as shown for gltA from the
archaean Pyrococcus (Jongsareejit et al., 1997).
The two enzymes that catalyse interconversion between aspartate
and asparagine, aspartate ammonia ligase (EC 6.3.1.1) and asparaginase
(EC 3.5.1.1; see Section 4.2.1), are present in E. histolytica. Two types of
aspartate ammonia ligases, AsnA and AsnB, are known from other organ-
isms: the former utilises only ammonia, while the latter uses both ammo-
nia and glutamine as amide donors in a reverse reaction. Mammals
possess only AsnA, whereas prokaryotes have both AsnA and AsnB
(Boehlein et al., 1996; Nakamura et al., 1981). Interestingly, E. histolytica
possesses only the AsnB homologue. Thus, the amoebic enzyme is likely
involved in the formation of glutamate from glutamine, in addition to
asparagine formation from aspartate.
4.4.3. Synthesis of glutamate and aspartate
Glutamate can be formed from 2-oxo-glutarate and ammonia in a revers-
ible reaction catalysed by glutamate dehydrogenase (EC 1.4.1.2), which is
present in E. histolytica. It is known that this enzyme plays a dominant role
in ammonia fixation under ammonia-non-restricted conditions as this
reaction consumes no ATP. In addition, glutamate dehydrogenase is
also involved in gluconeogenesis from glutamate.
Aspartate ammonia-lyase (synonymous with aspartase, EC 4.3.1.1),
which decomposes aspartate into fumarate and ammonia in a reversible
reaction, is also present in E. histolytica (see Section 4.2.1).
4.5. Lipid metabolism
For E. histolytica, the lack of oxidative phosphorylation means that the high
energy content of lipids such as fatty acids cannot be exploited. Therefore,
lipids such as phospholipids and cholesterol are primarily membrane
components in E. histolytica (Das et al., 2002; Sawyer et al., 1967). Although
these components are mainly acquired from their food or from the human
host, E. histolytica does have some capability for biosynthesis, as well as
extending and remodelling lipids, and for attaching lipids to proteins.
4.5.1. Lipid biosynthetic capabilities
4.5.1.1. Polyisoprene biosynthesis and protein prenylation Cholesterol is
an important membrane constituent generated from C5 isoprene precur-
sors. E. histolytica trophozoites in axenic culture need cholesterol in their
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growth medium (Reeves, 1984), and it is likely that they acquire it from
their human host. Reeves (1984) even cites several studies which show
that hypercholesteremia in the host increases the damage inflicted by
amoebic infection. E. histolytica lacks several enzymes for the classical
sterol biosynthesis pathway (Schroepfer, 1981). The first stage of sterol
biosynthesis is the formation of isopentenyl- or dimethylallyl diphos-
phate. In the E. histolytica genome no candidate genes for the generation
of these intermediates were found, neither for the mevalonate pathway
nor for the mevalonate-independent methylerythritol 4-phosphate (MEP)
pathway that operates in bacteria and plants (Hunter et al., 2003; Rohmer
et al., 1993). In a later step towards cholesterol synthesis, two molecules of
C15 farnesyl diphosphate are dimerised to give C30 presqualene diphos-
phate by squalene synthetase (EC 2.5.1.21). This enzyme activity and those
catalysing the subsequent steps also appear to be absent. The genome data
thus support the long-standing conclusion that cholesterol biosynthesis is
absent from E. histolytica.
Unexpectedly, the E. histolytica genome appears to encode enzymes
involved in the intermediate stages of cholesterol biosynthesis from C5
isopentenyl diphosphate to C15 farnesyl diphosphate. The latter com-
pound, and the larger C20 compound geranylgeranyl diphosphate, may
serve as precursors for the hydrophobic modification of GTP-binding
proteins allowing them to bind to membranes (Grunler et al., 1994).
Protein prenylation is a ubiquitous process. It is important in human
cell biology, health and disease (McTaggart, 2006), but it is also essential
for parasites such that protein farnesylation has been proposed as a
potential novel target for anti-parasitic chemotherapy (Maurer-Stroh
et al., 2003), including anti-E. histolytica chemotherapy (Ghosh et al., 2004).
The first enzyme in this pathway is the isopentenyl-diphosphate
d-isomerase that catalyses the conversion of isopentenyl diphosphate to
dimethylallyl diphosphate (EC 5.3.3.2). There is a single gene encoding
this enzyme that is of presumed bacterial origin and is on the list of
LGT candidates. The two isomeric C5 isoprenyl diphosphates undergo
condensation to C10 geranyl diphosphate, catalysed by geranyl-
diphosphate synthase (EC 2.5.1.1). Farnesyl-diphosphate synthase
(EC 2.5.1.10) then adds another C5 unit to give C15 farnesyl diphosphate.
Finally geranylgeranyl-diphosphate synthase (EC 2.5.1.29) adds another
C5 prenyl unit to give C20 geranylgeranyl diphosphate. The genome
contains five putative prenyl transferase genes, which all have been
annotated as geranylgeranyl-diphosphate synthases. Their sequences
are highly similar, with the exception that the ORFs are disrupted in
two of them (XP_650479 and XP_655958). These prenyl transferases
appear to be of bacterial origin as well, and XP_650913 is on the list of
LGT candidates. When searching for geranyl-diphosphate synthase or
farnesyl-diphosphate synthase in the E. histolytica genome, the closest
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matches are for the same genes, so that the substrate specificity of these
enzymes is unclear and needs to be examined biochemically.
The E. histolytica genome contains one sequence each for the a and b
chains of protein farnesyltransferase (EC 2.5.1.58), which were previously
cloned and characterised as recombinant proteins (Kumagai et al., 2004).
In addition to the protein farnesyltransferase, a protein geranylgeranyl-
transferase I (EC 2.5.1.59) b chain has recently been cloned and expressed
together with the protein farnesyltransferase a chain (Makioka et al., 2006).
The heterodimeric molecule had protein geranylgeranyltransferase
activity of unusually broad substrate specificity. The a and b chains of the
protein (Rab-)geranylgeranyltransferase II (EC 2.5.1.60) have also been
cloned, as cDNAs (M. Kumagai, A. Makioka, T. Takeuchi and T. Nozaki,
unpublished data).
The E. histolytica genome encodes candidate enzymes for the modifi-
cation of prenylated proteins. There are two highly divergent proteins
both identified as CAAX prenyl proteases (EC 3.4.24.84). CAAX is the
carboxy terminus of the substrate protein in which C is the prenylated
cysteine residue, A is an aliphatic amino acid and X is the terminal residue.
The proteases cleave after the modified cysteine. After the processing step,
a prenylcysteine carboxyl methyltransferase (EC 2.1.1.100) methylates
the carboxy-terminal residue; there are two divergent candidate genes for
this enzyme.
Taken together, the E. histolytica genome contains all the necessary
genes to encode the pathway from isopentenyl diphosphate to a pro-
cessed farnesylated or geranylgeranylated protein. The source of the
starting material, isopentenyl diphosphate, remains unknown at this
time, but there may be a previously unknown pathway for its synthesis
or E. histolytica may be able to aquire it from its environment.
4.5.1.2. Fatty acid biosynthesis E. histolytica encodes an unusual 138 kDa
acetyl-CoA carboxylase with 2 bacterial-type carboxylase domains,
an acetyl-CoA carboxylase and a pyruvate carboxylase. Since no biotin
carboxylase domain is found in the E. histolytica genome, it was proposed
that the enzyme removes a carboxyl group from oxaloacetate and trans-
fers it to acetyl-CoA, forming malonyl-CoA and pyruvate (Jordan et al.,
2003; Loftus et al., 2005). This fusion protein has not been identified in any
organisms other than Giardia and Entamoeba.
In the classical pathway of fatty acid biosynthesis, starting from acetyl-
CoA sequential two-carbon units are added from malonyl-CoA. In each
round of extension, the b-keto group is reduced in three steps before a
new two-carbon unit is added. The whole pathway is carried out in a
large fatty acid synthase complex, where the growing chain is linked to an
acyl carrier protein. E. histolytica lacks this classical pathway. There are,
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however, plant homologues of fatty acid chain elongases such as
Arabidopsis thaliana KCS1 (Todd et al., 1999). There are eight putative
fatty acid elongases in the E. histolytica genome, and all are very similar
to each other. These enzymes could be involved in elongation of fatty
acids taken up from the host or food sources, but their function and
substrate specificity are unknown at this time.
4.5.2. Phospholipid metabolism
Phospholipids amount to 60–70% of the total lipids in E. histolytica
(Sawyer et al., 1967). So far little information is available at the biochemical
level on how phospholipids are synthesised, acquired or remodelled. The
genome project has revealed a number of genes, indicating that the
phospholipid metabolism could be more complex than expected.
4.5.2.1. Phospholipid biosynthesis In order to produce phospholipids
one has to generate the important intermediate phosphadidate (1,2-
diacylglycerol 3-phosphate) by phosphorylation and acylation of glycerol.
E. histolytica contains one gene for a glycerol kinase (EC 2.7.1.30).
The second step would be the transfer of the acyl group to glycerol-3-
phosphate by glycerol-3-phosphate O-acyltransferase (EC 2.3.1.15), but
no candidate gene for this enzyme has been found in the genome. There
are, however, two potential 1-acylglycerol-3-phosphate O-acyltransferases
(EC 2.3.1.51) that could attach the second acyl group. After the attachment
of the acyl groups, and in preparation for the attachment of the
activated aminoalcohols, the phosphate is removed by phosphadidate
phosphatase (EC 3.1.3.4), for which there is one gene, resulting in a
diacylglycerol.
The activation of ethanolamine (EC 2.7.1.82) or choline (EC 2.7.1.32) for
attachment to the phosphadidate starts with phosphorylation. There are
two genes identified as choline/ethanolamine kinases that share 37%
amino acid identity. Next, ethanolamine phosphate and choline phos-
phate are converted into CDP-ethanolamine (EC 2.7.7.14) and CDP-
choline (EC 2.7.7.15), respectively. The genome encodes 2 enzymes sharing
57% sequence identity that are identified as ethanolamine-phosphate
cytidylyltransferases. The substrate specificity of these enzymes needs
to be examined on the biochemical level. Finally, the activated
ethanolamine or choline is attached to diacylglycerol by the enzymes
ethanolaminephosphotransferase (EC 2.7.8.1) or diacylglycerol choline-
phosphotransferase (EC 2.7.8.2) producing phosphatidylethanolamine
or phosphatidylcholine, respectively. For these activities a total of eight
possible genes are found that share varying degrees of sequence
similarity.
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In E. histolytica, an alternative pathway of phospholipid biosynthesis
could involve the biosynthesis of phosphatidylserine. In this pathway,
the phosphatidate itself is activated by CTP in a reaction catalysed by
phosphatidate cytidylyltransferase (EC 2.7.7.41) resulting in CDP-diacyl-
glycerol. Three genes have been identified. Phosphatidylserine synthase
then catalyses the reaction of CDP-diacylglycerol with serine to give
phosphatidylserine (EC 2.7.8.8); one gene has been found.
Some organisms can form phosphatidylethanolamine from phosphati-
dylserine using a decarboxylase, but such an enzyme appears to be absent
from the E. histolytica genome. There are, however, several candidate
methyltransferases of yet unknown substrate specificity, which might be
able to generate phosphatidylcholine from phosphatidylethanolamine.
Taken together, large portions of the pathways needed to generate the
most important phospholipids can be assembled from genes tentatively
identified to date in the E. histolytica genome. The first acylation of
glycerol 3-phosphate to lysophosphatidate remains an important gap.
As E. histolytica could potentially aquire all the necessary phospholipids
from the host, the functional relevance of the described biosynthetic
pathways may not be high.
Finally, two additional interesting enzymes present in E. histolytica
should be mentioned. The first was previously characterised using
cDNA sequences and recombinant proteins as L-myo-inositol 1-phosphate
synthase (EC 5.5.1.4; Lohia et al., 1999). This enzyme catalyses the compli-
cated isomerisation of glucose 6-phosphate to L-myo-inositol 1-phosphate.
Inositol is found in phosphatidylinositol (PI) and in GPI-anchors of some
membrane proteins, as well as playing a major role in signal transduction
via the secondary messenger 1,4,5-inositol trisphosphate. There are three
myo-inositol 1-phosphate synthase genes, all highly similar to each other
and to the previously sequenced cDNA.
The second is phospholipid-cholesterol acyltransferase (EC 2.3.1.43),
which transfers an acyl group from phospholipids such as phosphatidyl-
choline to cholesterol giving a cholesterol ester. The genome contains seven
genes for this enzyme. So far nothing is known about the importance of
cholesterol esters for E. histolytica.
4.5.2.2. Phospholipid degradation Phospholipids are degraded by phos-
pholipases. Whereas phospholipases A1 (EC 3.1.1.32) and A2 (EC 3.1.1.4)
cleave the acyl residues in the 1 or 2 position of the glycerol core, phos-
pholipases C (EC 3.1.4.3) and D (EC 3.1.4.4) cleave at the phosphate,
phospholipase C on the glycerol side, and phospholipase D on the ami-
noalcohol side. In E. histolytica phospholipase A activity has been impli-
cated in virulence (Ravdin et al., 1985), as it liberates toxic fatty acids and
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lysophospholipids (Said-Fernandez and Lopez-Revilla, 1988). Phospholi-
pases A have been found in two forms, a membrane-bound Ca-dependent
form active at alkaline pH and a soluble Ca-independent form active at
acid pH (Long-Krug et al., 1985; Vargas-Villarreal et al., 1998). The genome
encodes 11 potential phospholipases A with predicted pI values between
4.8 and 8.8 and various degrees of sequence similarity. In addition, the
E. histolytica genome encodes three potential phospholipases D.
Finally, there are two highly similar genes for phospholipases C, but
these are homologous to PI-specific phospholipases C (EC 3.1.4.11) and
most likely do not cleave PI or phosphatidylcholine but GPI-anchors
instead. So far there are no studies using individual recombinant phos-
pholipases, and it is not yet known how much these enzymes may
contribute to the virulence of E. histolytica.
4.6. Coenzyme A biosynthesis and pantothenate metabolism
Analysis of the genome revealed a complete lack of known folate-
dependent enzymes and folate transporters, suggesting this cofactor is
not utilised by E. histolytica. This is at odds with a study on the nutritional
requirements of E. histolytica in which folate was found to be essential for
growth (Diamond and Cunnick, 1991). More experimental research will
be needed to resolve this discrepancy. Most organisms require folate as a
cofactor for several reactions of amino acid metabolism and for synthesis
of thymidylate, a component of DNA. The microsporidian E. cuniculi,
which possesses the smallest-known eukaryotic genome, still contains a
folate transporter and several folate-dependent enzymes (Katinka et al.,
2001). In eukaryotes possessing mitochondria or chloroplasts, folate is
required for the formylation of methionine on the initiator tRNA used
for organelle protein synthesis. Although E. histolytica possesses a
mitochondrion-derived organelle, the mitosome, there is no organellar
genome (Leon-Avila and Tovar, 2004) and so no need for organellar
protein synthesis. The most important metabolic consequences of the
loss of folate metabolism for E. histolytica are therefore the absence of
thymidylate synthesis and methionine recycling, although it remains
possible that E. histolytica possesses folate-independent enzymes carrying
out these steps.
Phosphopantothenoyl-cysteine decarboxylase (EC 4.1.1.36) and
phosphopantothenoyl-cysteine synthetase (EC 6.3.2.5, synonymous
with phosphopantothenate-cysteine ligase) exist as a fusion protein in
E. histolytica, as in Bacteria and Archaea. The amino- and carboxyl-terminal
domains possess decarboxylase and synthetase activity, respectively
(Kupke, 2002, 2004; Kupke et al., 2000; Strauss et al., 2001). The role of this
enzyme in coenzyme A biosynthesis is not well understood in E. histolytica
as the other necessary enzymes are absent.
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1. Introduction
Entamoeba histolytica causes amoebic dysentery and liver 
abscess and is responsible for widespread morbidity and mortality
(World Health Organization, 1997). The nitroimidazole drug met-
ronidazole has been used successfully to treat invasive amoebiasis
since 1966 (Powell et al., 1966) and has since then remained the 
gold standard for amoebiasis treatment. Metronidazole needs to 
be reduced in the parasite in order to become active (Müller, 1983).
In trichomonads, reduced ferredoxin formed in the pyruvate: fer-
redoxin oxidoreductase (PFOR) reaction is believed to reduce 
metronidazole. In vitro data corroborate this hypothesis (Lindmark 
and Müller, 1976). Since PFOR is also an abundant enzyme in
E. histolytica, the same mechanism is suggested to exist in
E. histolytica. Recently, we have been able to show that the ﬂavin
enzyme thioredoxin reductase is also able to reduce and activate 
metronidazole and other nitro compounds (Leitsch et al., 2007).
The activated reaction products such as the nitroradical anion and 
further reduced intermediates then attack cellular components of 
the parasite, in particular proteins and other thiol containing com-
pounds. We were also able to deﬁne for the ﬁrst time speciﬁc pro-
tein targets of these activated metabolites, the activating enzyme 
thioredoxin reductase, as well as thioredoxin, superoxide dismu-
tase and purine nucleoside phosphorylase (Leitsch et al., 2007).
This work showed that the target proteins were chemically modi-
ﬁed, most likely via protein thiol groups, because cysteine was able 
to rescue E. histolytica from the toxic effects of metronidazole.
The selective poisoning of E. histolytica by metronidazole in vitro 
and in the human host has been an extremely successful example
of anti-parasite chemotherapy for more than 40 years. Although 
considerable information is available on the activation of metroni-
dazole and other nitroimidazoles, and we are learning more about 
protein targets, little is known if and how E. histolytica responds 
to the chemical stress elicited by metronidazole by changing the 
levels of mRNA and protein expression.
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The development of transfection methods for E. histolytica
(Nickel and Tannich, 1994; Purdy et al., 1994) has paved the way 
for the identiﬁcation of a core promoter structure consisting of a 
TATA-like element with the consensus sequence GTATTTAAAG/C,
followed by a GAAC element, and an AAAAATTCAA element mark-
ing the transcriptional start site (reviewed by Vanacova et al., 
2003). The availability of the genome data (Loftus et al., 2005)
and microarrays to measure the baseline level of transcription
was recently exploited to predict more promoter elements, which 
could also be veriﬁed by speciﬁc interaction of proteins with the 
elements (Hackney et al., 2007). Some of the elements in combina-
tion render the downstream genes heat-inducible.
Entamoeba histolytica trophozoites respond strongly to elevated 
temperatures. Shifting the temperature to 40°C for 5h led to a 
signiﬁ  cant induction of mRNA coding for Hsp70, the 70kDa heat 
shock protein (Ortner et al., 1992). Recently, the mRNA expression
changes upon heat shock (42 °C for 4h) were examined in detail 
by microarray hybridization (Weber et al., 2006). Hsp70 and other 
heat shock proteins and chaperones were up-regulated as well as 
the cysteine proteinases Cp4 and Cp6, which are possibly involved 
in the degradation of damaged proteins. Surprisingly, the study 
revealed a vast down-regulation of mRNAs coding for as many as 
42% of all unique proteins examined. So studying the heat shock 
response leads to a number of new questions, even complicated by 
an earlier observation that epigenetic regulation may also play a 
role in this response (Bernes et al., 2005).
The response of E. histolytica trophozoites to the mouse host 
in an intestinal infection model led to extensive mRNA expres-
sion changes for genes implicated in metabolism, oxygen defense, 
cell signaling, virulence, antibacterial activity, and DNA binding
(Gilchrist et al., 2006). Even the addition of human type I colla-
gen alone led to signiﬁ  cant expression changes of genes involved 
in cell signaling, cytoskeletal reorganisation, and vesicle formation
as well as inducing cysteine proteinase and amoebapore mRNAs
(Debnath et al., 2004).
In the present work, we examined the response of the amoebae
to metronidazole using a 213 gene focused microarray, quantitative 
RT-PCR, and two-dimensional gel electrophoresis. Taken together, 
E. histolytica was unable to mount a strong, coordinated response 
to this lethal stress. Transcription of a limited number of mRNAs
was up-regulated within one hour, but there was no signiﬁ  cant
further rise of these mRNA levels. When we examined the solu-
ble proteome of the amoebae, we did not detect any up-regulated 
proteins, only the products of modiﬁcation by activated metroni-
dazole metabolites as described above.
2. Materials and methods
2.1. Parasite culture
Entamoeba histolytica trophozoites (HM-1:IMSS) were grown 
axenically at 36.5°C in TYI-S-33 medium supplemented with 10% 
(v/v) complement-inactivated bovine serum (Diamond et al., 1978).
The medium in the 25ml tissue culture ﬂasks (BD Biosciences,
Heidelberg, Germany) was changed every three days.
2.2. Metronidazole treatment
Six culture ﬂasks of log phase E. histolytica cells were pooled, 
counted and then again distributed to six new ﬂasks. Metronidazole 
(Anaerobex 0.5%, Gerot Pharmaceuticals, Vienna, Austria) was added 
to three culture ﬂasks each to give a ﬁnal concentration of 50?M,
three ﬂasks remained untreated as control. After 1h, 3h, and 5h, one 
treated and one untreated ﬂask of cells were used to prepare total 
RNA. The drug concentration of 50?M was used as it is somewhat 
lower as the peak plasma concentration (50–80?M) after one oral 
dose of 500mg (Lamp et al., 1999). At this concentration, after 5h, 
the amoebae had rounded off but were still alive, whereas after 24h, 
only about 2% had survived as judged by Trypan blue exclusion. The 
same treatment scheme was used for two-dimensional gel electro-
phoresis (2DE), and samples for microarray and proteome analysis 
were derived from the same batch of amoebae.
2.3. Extraction of total RNA
Isolation of total RNA was performed using Tri Reagent 
(Sigma–Aldrich, Vienna, Austria) according to the instructions of 
the supplier. Brieﬂy, the sedimented cells were lysed with 1ml
Tri Reagent per 5–10£106 cells, proteins were extracted into the 
phenolic phase, and RNA was isopropanol precipitated from the 
aqueous phase. The resulting pellet was washed with 75% ethanol,
air-dried, and dissolved in diethylpyrocarbonate (DEPC)-treated 
water. Samples were stored at ¡80 °C.
2.4. Generation of ﬂuorescently labeled cDNA probes
For generation of labeled probes, 8?g of total RNA was spiked 
with test or reference spike mix, respectively (Lucidea Universal 
ScoreCard, Amersham, GE Healthcare, Vienna, Austria), oligo(dT)
and water added and annealing was allowed while cooling from 
70°C to 4°C in a PCR machine. For cDNA synthesis the Atlas Power-
Script Fluorescent Labeling Kit (BD Biosciences, Rockville, MD, USA) 
was used, the mastermix containing 5£ cDNA synthesis buffer, 10£
dNTP mix containing aminoallyl-dUTP, DTT, Powerscript Reverse 
Transcriptase and RNaseOUT (Invitrogen, Lofer, Austria). Transcrip-
tion was allowed to proceed for 60min at 45°C, then the samples 
were heated to 70°C for 5min, cooled to 37°C, and 0.2?l RNase H 
(10U ?l¡1) were added and incubated for 15min at 37°C. The sam-
ple was then cleaned with 2?l of QuickClean Enzyme Removal Resin 
(Clontech, Vienna, Austria), and the cDNA was ethanol-precipitated, 
washed with 70% ethanol, air-dried, and resuspended in 10?l of 2£
Fluorescent Labeling Buffer. Labeling was performed with Cy3 (refer-
ence) and Cy5 (test) Mono-Reactive Dye Pack (Amersham, GE Health-
care), respectively, for 60min at room temperature. Final purifying of 
the labeled cDNA was done with the QIAquick PCR puriﬁcation kit 
(Qiagen, Hilden, Germany), or, alternatively, with the BD puriﬁcation 
kit contained in the Atlas system. Samples were stored in light-proof 
tubes until hybridization.
2.5. Construction of a focused microarray
The design for the low density oligonucleotide array was done 
with OligoWiz 2.0, a free academic program (www.cbs.dtu.dk/ ser-
vices/OligoWiz2/) from the Center for Biological Sequence Analysis
at the Technical University of Denmark in Lyngby (Wernersson
and Nielsen, 2005; Nielsen et al., 2003), applying standard param-
eters except for setting the low complexity threshold to 1.5. The 
oligonucleotides had a length between 45 and 55 nucleotides with 
an average of 47.1. A full list of all 213 genes, accession numbers, 
and oligonucleotide sequences can be found in Supplementary 
Table 1. All oligonucleotides were synthesized with a 5?-amino
modiﬁcation (Microsynth, Balgach, Switzerland), and spotted onto 
epoxy-modiﬁed CodeLink Activated Slides (GE Healthcare).
Spotting was performed on a GeneMachines OmniGrid 100 
(BST Scientiﬁc, Singapore) with the following conﬁguration: pin 
conﬁguration 4£4, array size 8£9, spacing 400£400, spotting
buffer 150mM sodium phosphate, 0.001% SDS, pH 8.5, 25?M oli-
gonucleotide probe. Humidity was 45%, temperature 22°C, post 
coupling was performed according to the CodeLink protocol. All 
oligonucleotides were spotted in triplicate. The whole set was 
spotted twice per slide, so each slide contained six spots of a given 
oligonucleotide.
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2.6. Microarray hybridization and data analysis
Labeled Cy3 and Cy5 probes were combined in one tube and 
lyophilized. Meanwhile the CodeLink slides were blocked with pre-
hybridization buffer (6£ SSC, 2.5% SDS, 1% BSA, total of 40ml) for 
45min at 42 °C, then washed with MilliQ water and 95% EtOH and 
dried in a centrifuge. Coverslips were washed with MilliQ water 
and isopropanol and spun dry. The dry, labeled cDNA was dissolved 
in 40?l of pre-warmed (50°C) hybridization buffer (30% formam-
ide, 5£ Denhart´s solution, 5£ SSC, 1mM sodium pyrophosphate, 
50mM Tris pH 7.4, 0.1% SDS), denatured at 95°C for 4min and then 
placed onto the slide. Hybridization was performed overnight for 
16h at 30°C in the HybChamber from GeneMachines (Genomic
Solutions, Zinsser Analytic, Frankfurt, Germany), moisturized with 
10?l 1£ SSC. After hybridization, slides were removed from the 
chamber and washed in solutions of decreasing ionic strength (4£
SSC at room temperature to remove the cover slip; 2£ SSC, 0.1% 
SDS at hybridization temperature twice for 5min each; 0.2£ SSC
at room temperature for 1 min; 0.1£ SSC at room temperature for 
1min; followed by brieﬂy dipping in pure water at room tempera-
ture) and then spin-dried at 2500rpm for 4min.
The microarrays were scanned with a GenePix 4000A scanner 
(Axon Instruments, Union City, CA, USA) at 10?m resolution, 
analysis of the resulting images was performed with the GenePix
Pro 4.1 software from Axon Instruments. Automated spot detec-
tion, manual and automated ﬂagging as well as calculation of 
Cy5/Cy3 ratios was done with this program, normalization was 
performed according to the GenePix normalization factor such 
that the median of ratios value is 1. Data were exported to a 
Microsoft Excel calculation sheet and the median of the median 
of ratios of all detected spots per oligonucleotide (maximum of 
six) was calculated. Geometric means of medians for each gene 
and treatment time were obtained and after log-normal trans-
formation, the signiﬁ  cance of up-regulation or down-regulation 
of the respective genes was assessed by means of the Student´s
t-test for independent samples. Values with p-values < 0.05 were 
considered as signiﬁ  cant.
2.7. Quantitative real-time reverse transcription-PCR (qRT-PCR)
The design of primer sequences for qRT-PCR (Supplementary 
Table 2) was performed with the Primer Express, version 2.0, soft-
ware (Applied Biosystems, Foster City, USA). Primers were designed 
to target single exons which requires careful examination of minus 
RT controls (see below). Each amplicon was tested for potential 
secondary structures and for speciﬁcity using the Mfold web server 
(Zuker, 2003) and the Basic Local Alignment Search Tool BLASTn
(Altschul et al., 1990), respectively. Amplicon sizes were between 
60 and 137basepairs (Supplementary Table 2).
Total RNA amount was measured spectrophotometrically on 
the Hellma TrayCell (Hellma, Müllheim/Baden, Germany) in com-
bination with the BioPhotometer 6131 (Eppendorf, Hamburg, 
Germany). The integrity of each RNA sample was assessed by the 
2100 Expert software (version B.02.03.SI307) of the 2100 Bioan-
alyzer (Agilent Technologies, Santa Clara, USA) using the RNA 
6000 Nano Chip Kit (Agilent Technologies) and 200 ng of input 
RNA. To overcome failure to compute an RNA integrity number 
(RIN) value by the Bioanalyzer software, the anomaly thresh-
old settings for the 5S region (advanced settings in the Set Point 
Explorer) were adjusted manually within a range of +0.1– +0.2 of 
the default value. A RIN value of ﬁve was used as threshold for 
qRT-PCR analysis (Fleige and Pfaﬄ, 2006). Sample RINs ranged 
from 5.0 to 6.5.
The High-Capacity Reverse Transcription Kit (Applied 
Biosystems) was used for reverse transcription for 120min at 
37°C, primed with random RT primers. For each cDNA dupli-
cate 1.5?g of RNA was reverse transcribed in a reaction volume
of 20?l. The 20?l-qPCR consisted of 80mM Tris–HCl (pH 9.4), 
20mM (NH4)2SO4, 0.02% w/v Tween-20, 3.5mM MgCl2, 0.2mM
dNTPs, 200nM of each primer, 0.4£ EvaGreen dsDNA-binding dye 
(Biotium, Hayward, USA), 1U of a Taq DNA polymerase chemically 
modiﬁed for “hot start” (Hot FIREPol, Solis Biodyne, Tartu, Estonia)
and 1.5?l cDNA template. The qPCR was conducted on the ABI
PRISM 7900HT Sequence Detection System (Applied Biosystems) 
using a thermal protocol which consisted of an initial hot start at 
95°C for 15min followed by 40 ampliﬁcation cycles (95°C for 15s,
59°C for 40 s, 72 °C for 20 s). A series of ﬁve eight-fold dilutions
of a randomly selected control cDNA ampliﬁed in duplicate was 
used to generate a standard curve. Reaction eﬃciencies (E) calcu-
lated from the slope (s) of the standard curve using the formula
E=10¡1/s ranged from 70% to 90%.
RNA speciﬁcity of a qRT-PCR signal was concluded if the 
difference between the threshold cycle (CT) values of a sample
and its “minus-RT” control was above 9.5. This ?CT requirement
calculated for assays with lower ampliﬁcation eﬃciencies (E =0.7)
would correspond to a systematic error of about 1%.
Calculation of gene expression ratios and evaluation of their 
statistical signiﬁ  cance were performed using the Relative Expres-
sion Software Tool (REST) 2005 software including the Pair Wise 
Fixed Reallocation Randomisation Test (Pfaﬄ et al., 2002). To 
achieve accurate normalization for differences in the quantity
and quality of total nucleic acid added to each reaction and the 
eﬃciency of the RT step, a multiple reference gene normalization
strategy was applied. The housekeeping genes thioredoxin reduc-
tase and hexokinase 2 displaying minimal variation across the 
treatment and non-treatment control groups (1.4- and 1.5-fold, 
respectively.) were selected to normalize the gene of interest to 
their geometric mean. Finally, the n-fold expression of the gene 
of interest was given relative to a reference (three sham-treated 
control samples at the respective time point).
2.8. Cell harvest and preparation of lysates
Preparation of lysates and 2DE were carried out as described 
before (Leitsch et al., 2005). Brieﬂy, cells were harvested by 
centrifugation, washed, and disrupted in a Dounce homogenizer. 
Proteins were precipitated in 10% trichloroacetic acid in acetone 
at ¡20 °C for at least 90 min. After precipitation, proteins were 
pelleted in the ultracentrifuge, the pellet was washed twice with 
90% (v/v) acetone in H2O, and air-dried. Proteins were resuspended 
at room temperature in 2DE solubilization buffer (7M urea, 2M
thiourea, 4% (w/v) CHAPS (3-[(3-cholamidopropyl)dimethylam-
monio]-1-propanesulfonate), 1% (w/v) DTT (dithiothreitol), and 1% 
(v/v) Pharmalyte pH 3–10 ampholytes (GE Healthcare)). Insoluble
material was removed by ultracentrifugation. Protein concentra-
tion was determined by Bradford assay (Bio-Rad Laboratories).
2.9. Two-dimensional polyacrylamide gel electrophoresis (2DE)
Fifty microgram protein for silver-stained, and 500?g protein 
for Coomassie-stained gels, were diluted in rehydration buffer 
(7M urea, 2 M thiourea, 0.5% (w/v) CHAPS (3-[(3-cholamidopro-
pyl)dimethylammonio]-1-propanesulfonate), 15mM DTT, and 
0.2% (v/v) ampholytes pH 3–10) up to a total volume of 350?l. Iso-
electric focussing was performed with 17cm pH 3–10 (nonlinear)
IPG strips in a Bio-Rad IEF cell (Bio-Rad Laboratories), and in the 
second dimension 12.5% PAGE was run. Gels were silver-stained 
to visualize as many spots as possible, whereas gels were stained 
with Coomassie Brilliant Blue R-250 (Bio-Rad) for better quanti-
ﬁcation. Gels were scanned with an Epson 1680 Pro scanner and 
analyzed with the Melanie 2D gel analysis software (GeneBio,
Geneva, Switzerland).
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3. Results
3.1.  A focused microarray containing 213 oligonucleotide probes
To measure the mRNA expression changes we constructed 
a focused oligonucleotide microarray for 213 selected target 
genes. When we started the work, large amounts of sequence 
data was available from the Institute for Genomic Research 
(http://www.tigr.org) and the Sanger Institute (http://www.san-
ger.ac.uk), but the gene annotations had not been made. So we 
constructed a database from own annotations made by TBLASTN
(Gertz et al., 2006) searches starting with eukaryotic or pro-
karyotic query sequences (Hofer and Duchêne, 2005). We ﬁnally 
selected 213 genes from our database and, in a few cases, from 
previously published genes. The largest group were genes coding
for enzymes (n =110), a second group codes for cytoskeletal genes 
initially thought to represent typical housekeeping genes (n =76), 
a third group of stress genes (n =15), and ﬁnally a small number of 
known or putative surface antigens (n =12). On the one hand, our 
array was limited to cover only a rather narrow part of the genome, 
but it contained only selected genes with known homologs, in 
particular, genes possibly involved in activation of or resistance 
to metronidazole (Wassmann et al., 1999). Supplementary Table 
1 displays the whole list of genes and deduced oligonucleotide
probes, also including the updated “XM” genome project accession
numbers and accession numbers relating to previous publications.
It may be noted that there is a high number of lipid-associated 
enzymes. These were on the array for examining the reaction to 
the anti-amoebic agent miltefosine (Seifert et al., 2001).
The design of the oligonucleotide probes is described above. A 
compromise had to be found when designing the probes between 
short probes serving the intention of distinguishing members of 
a gene family and long probes permitting stronger hybridization
allowing stringent washes. Our probes had an average A/T content 
of 64.4% and had an average length of 47.1 nucleotides, this required 
mild hybridization and washing conditions at only 30°C.
3.2.  Optimization of treatment and array conditions
After performing some preliminary experiments, a metronida-
zole concentration of 50?M was chosen for all experiments. After 
24h, this concentration killed 98% of the amoebae, but after 5h
the amoebae were still alive and intact although they had lost their 
elongated shape. So when we analyzed amoebae treated for 1h,
3h, and 5h in the ﬁnal experiments, we examined them from the 
moment of drug addition to a time with visible changes. During
this period we expected the maximum response of the cells to the 
lethal challenge.
As the cleaning step of the labeled cDNA is an important step, 
we compared two procedures, the QIAquick PCR puriﬁcation kit 
and the BD puriﬁcation kit contained in the Atlas system. Two 
sets of metronidazole-treated samples and controls were gener-
ated with a short exposure time of 1 h, and cDNAs were puriﬁed 
with the QIAquick kit or the BD kit. As we observed no signiﬁ  cant
systematic difference between the two samples (data not shown), 
we included both experiments in the ﬁnal statistics. In all the 
further experiments, the labeled cDNAs were puriﬁed with the 
QIAquick kit.
Table 1A
Up-regulated genes upon metronidazole treatment of E. histolytica
Up-regulated genes Accession Numbers 1h 3h 5h 1h 3h 5h
Microarray qRT-PCR
Fe superoxide dismutase XM_643735,
M63816, X70852
1.6* 2.2 **** 1.4
Thioredoxin reductase XM_650656,
XM_643726, X79603
1.8 1.8* 1.6
Thioredoxin XM_651634 n.a. n.a. n.a. 1.4 1.6* 2.1
Peroxiredoxin XM_647979,
XM_646911,
XM_644418,
XM_644379,
XM_643430,
XM_642815,
XM_642754,
EHU67158,
EHU67157
2.4 2.5* 1.6
Ferredoxin XM_650091,
XM_650090, J03970
2.1** 2.9** 1.8***
Ferredoxin XM_646192 2.2*** 2.6**** 2.5*** 2.7*** 2.0* 3.8***
Ferredoxin XM_648587 1.8* 1.9 1.6
Lectin heavy subunit XM_651089, X89415,
M60498
2.1 1.8** 2.3* 2.0* 2.6** 1.7
Lectin light subunit XM_646286 2.5* 2.1*** 2.1*** 1.3 1.8* 3.3*
Hexokinase 1 XM_648528, X82197 1.5 1.8* 2.0
Hexokinase 2 XM_650873, X82198 1.6 1.7 2.0
Long chain fatty acid CoA ligase XM_651318 2.3* 2.0* 2.1*** 1.9* 4.2*** 4.9***
Diacylglycerol kinase XM_646834 1.6 1.8* 1.7
GTP binding protein beta chain XM_651512 1.7 1.7** 1.9
Ubiquitin UBI1 XM_645071,
XM_645435, X98567
2.9 1.9 1.9
Ubiquitin XM_650087,
XM_643062,
XM_649937
2.2 2.2 1.9
n.a.: Not analyzed.
* p60.05.
** p60.01.
***p60.005.
**** p60.001.
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3.3.  Metronidazole treatment elicits modest changes in mRNA 
expression in E. histolytica trophozoites
For the main experiment, new cultures were grown, and the 
amoebae now were treated with 50?M metronidazole for 1h, 3h,
and 5h as described above, together with the untreated parallel
cultures. Two independent experiments were performed labeling
the cDNAs with Cy3 (control) and Cy5 (metronidazole-treated) 
ﬂuorescent dyes. Each of the six pairs of labeled samples were 
hybridized to the microarray as described above. The analysis of 
the microarray data, described in Materials and Methods (Section
2.6.), led to the ﬁnal data summarized in Table 1A (up-regulated 
genes) and Table 1B (down-regulated genes).
Taken together, there were only modest changes in mRNA 
expression in the amoebae for the genes selected for our microarray. 
Table 1A contains 15 genes with a tendency for up-regulation. Out 
of these, seven genes showed at least one statistically signiﬁ  cant
(p<0.05) value 72.0-fold change. These were the superoxide dis-
mutase, peroxiredoxin, two ferredoxin genes, the Gal/GalNAc spe-
ciﬁc lectin light and heavy chains, and a long chain fatty acid CoA
ligase. Only two genes encoding one of the ferredoxins and the 
lectin light chain were consistently above a factor of 2.0. Table 1B
shows eight genes with a tendency towards down-regulation, six
of which showed signiﬁ  cant (p<0.05) values of60.5 for at least 
one of the treatment times. These were genes encoding an actin, 
the 101 kDa heat shock protein, a short chain dehydrogenase, a 
fatty acid elongase, diaphanous protein, and a WD repeat protein. 
Although the changes observed were modest, those small changes 
occurred consistently.
For seven selected genes we also performed qRT-PCR using 
sequence-speciﬁc primers and the cDNAs from treated and 
untreated amoebae as a template. The right columns of Tables 1A 
and 1B show the relative expression values of these genes. The 
expression changes observed with this gold standard assay were 
also modest, and where the array had shown up-regulation or 
down-regulation, the qRT-PCR gave the same results. The factors 
were very similar in most cases, only for the 3h and 5h values for 
the long chain fatty acid CoA ligase gene, the qRT-PCR showed a 
markedly higher up-regulation than was observed in the micro-
array. Taken together, although the changes observed in the array 
experiments were not dramatic, they were clearly conﬁrmed by 
qRT-PCR, the gold standard assay.
3.4.  Metronidazole treatment and protein levels in the soluble
proteome of E. histolytica trophozoites
It was a main aim of the project to investigate the changes in 
metronidazole-treated amoebae both on the mRNA and protein 
levels, as in other organisms it had become clear that there is 
only a limited correlation with the protein and mRNA levels, for 
example in yeast (Gygi et al., 1999). So we knew from previous
experiments that metronidazole treatment led only to few pro-
tein changes in the amoebae, and these changes were associated 
with the modiﬁcation of ﬁve proteins in total by reduced metro-
nidazole metabolites (Leitsch et al., 2007). These processes told 
us more about the mechanism of the drug´s action than about the 
response of the amoebae. So for the present work we repeated the 
experiments again using 50?M of metronidazole for 1h, 3h, and 
5h, extracted the soluble proteome and performed 2DE. Both silver 
and Coomassie-stained gels were generated, but we did not ﬁnd 
any appearing or disappearing, or strongly up- or down-regulated 
protein spots (gels not shown). The only changes we observed 
were again the appearance of metronidazole-modiﬁed proteins 
(Leitsch et al., 2007) in the gels from the treated amoebae. Fig. 1
shows the spots from Coomassie-stained gels that had been identi-
ﬁed as thioredoxin, superoxide dismutase, thioredoxin reductase, 
actin, and the 70kDa heat shock protein, all of which had shown 
some changes on the mRNA level. Only in the metronidazole-
treated cells, thioredoxin and superoxide dismutase developed a 
modiﬁed sister spot shifted to the basic region (to the right in Fig. 
1.), and thioredoxin reductase developed two extra spots. Although 
the three genes superoxide dismutase, thioredoxin reductase, and 
thioredoxin were found to be slightly up-regulated on the mRNA 
level, this was not reﬂected on the level of protein. Actin and Hsp70 
had been found to be slightly down-regulated on the mRNA level. 
On the protein level, there is no visible effect in the 1h and 3h
Table 1B
Down-regulated genes upon metronidazole treatment of E. histolytica
Down-regulated genes Accession numbers 1h 3h 5h 1h 3h 5h
Microarray qRT-PCR
Actin XM_649111 0.7 0.7 0.4*** 1.0 0.6 0.6*
Actin XM_647886 0.8 0.6 0.6***
70kDa heat shock protein XM_646910 0.6 0.4 0.5
101kDa heat shock protein XM_648360,
XM_647538,
XM_643852,
XM_643174,
XM_648976,
XM_646042,
XM_645824,
XM_643226,
XM_643122,
XM_642790
0.8 0.3* 0.8
Short chain dehydro-genase XM_647586 0.5 0.5*** 0.5**
Fatty acid elongase XM_649311 0.6 0.6**** 0.4* 0.7 0.4* 0.5
Diaphanous protein XM_650938 0.6 0.4* 0.6
WD repeat protein XM_645831 0.8 0.4*** 0.7
Note. RNAs from E. histolytica trophozoites treated for 1 h to 5 h with 50?M metronidazole and controls were transcribed into either Cy3-labeled (control) or Cy5-labeled 
(treated) cDNAs and hybridized to a focused oligonucleotide microarray containing probes for 213 genes. Values for trophozoites treated for 1h, 3h, or 5 h were analyzed 
separately (3 left columns). Table 1A shows up-regulated genes, and Table 1B down-regulated genes. The results of the qRT-PCR for 7 selected genes are shown in the 3 right 
columns.
* p60.05.
** p60.01
***p60.005.
**** p60.001.
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treated cells, but there appeared to be a slight down-regulation
of Hsp70 after 5h. Image analysis showed, however, that the spot 
volume was only decreased by 10% which is below the threshold of 
signiﬁ  cance. Taken together, the amoebae are not able to transform 
the up-regulated mRNAs in a visible protein increase, underscor-
ing the impression of a defensive, catabolic state of the cells.
4. Discussion
To encounter challenges like heat shock, the conditions
favouring cyst formation, or contact with host molecules is a typ-
ical situation for E. histolytica, quite unlike the contact with met-
ronidazole. So it may not be surprising that the amoebae do not 
mount a strong and coordinated response to the drug, and mRNA 
expression changes are only modest. Several of the up-regulated 
genes (superoxide dismutase, peroxiredoxin, thioredoxin reduc-
tase and thioredoxin) belong to the factors destined to protect the 
amoebae from oxidative stress. When metronidazole is activated 
by a one-electron reduction, a nitroradical anion is produced. This 
anion or its further reduction products can damage cellular com-
ponents in a number of ways (Leitsch et al., 2007). In the pres-
ence of oxygen, the nitroradical anions can also generate oxida-
tive stress by reacting with this oxygen to form superoxide radical
anions. These can be detoxiﬁed in the amoebae by the combined 
action of superoxide dismutase and peroxiredoxin, therefore the 
up-regulation of these genes would be an appropriate reaction.
When E. histolytica is slowly adapted in vitro to increased (10–40
?M) metronidazole concentrations, the amoebae also up-regulate 
both superoxide dismutase and peroxiredoxin (Samarawickrema
et al., 1997; Wassmann et al., 1999).
In contrast to this potentially useful response, several ferredoxin 
genes are also up-regulated which could help in generating energy, 
but at the same time might lead to an increased activation of 
metronidazole by these newly generated ferredoxins. We also 
found thioredoxin reductase to be slightly up-regulated (Table 1A). 
On the one hand, thioredoxin reductase and thioredoxin together 
with peroxiredoxin can detoxify the hydrogen peroxide generated 
from superoxide anions by superoxide dismutase, on the other hand 
thioredoxin reductase is also able to reduce and activate metronida-
zole (Leitsch et al., 2007), to up-regulate this molecule would there-
fore be another counterproductive reaction of the amoebae. Indeed, 
in amoebae adapted to 40?M metronidazole during very prolonged 
drug pressure, thioredoxin reductase and ferredoxin 1 were now 
found to be down-regulated (Wassmann et al., 1999).
An interesting ﬁnding is the up-regulation both heavy and light 
chains of the galactose/N-acetylgalactosamine speciﬁc lectin. We 
cannot provide an obvious explanation why the main adhesion
factor of the amoebae should be up-regulated, however, it was 
demonstrated recently (Hughes et al., 2003) that the cytoplasmic
domain of the lectin heavy chain interacts with the antioxidant
peroxiredoxin. The authors concluded that the lectin may help to 
recruit peroxiredoxin to the cell surface, so a coordinated up-regu-
lation of peroxiredoxin and lectin genes could be imagined.
The E. histolytica genome contains ﬁve highly similar full-
length ubiquitin genes (Wostmann et al., 1996; Loftus et al., 2005)
represented by two ubiquitin probes in the array. Both cDNAs were 
up-regulated in the metronidazole-treated amoebae by a fac-
tor of about two. A speculation about a possible up-regulation of 
degradation is certainly premature in view of the complexities of 
the ubiquitin-proteasome system (Demartino and Gillette, 2007).
The very mild up-regulation of both hexokinases may be seen 
as another weak attempt to increase energy generation. Metabolic
modeling of E. histolytica glycolysis recently predicted that hexo-
kinase together with 3-phosphoglycerate mutase would exert ﬂux 
control of glycolysis at low substrate and product concentrations
(Moreno-Sánchez et al., 2008), so hexokinase up-regulation might 
indeed increase the rate of glycolysis. Interestingly, Trichomonas
vaginalis and Tritrichomonas foetus, in the process of developing
anaerobic resistance to metronidazole, although shutting off PFOR
and hydrogenase, nevertheless, increased their rate of glycolysis
(Kulda et al., 1989).
The expression of both the 70 kDa and 101kDa heat shock 
proteins was down-regulated. This was unexpected at ﬁrst, as 
oxidative stress is able to up-regulate Hsp70 in E. histolytica (Akbar
et al., 2004), nevertheless there are other examples, eg., the treat-
ment of cancer cells with resveratrol which signiﬁ  cantly down-
regulates Hsp70 mRNA and protein (Chakraborty et al., 2008).
Finally two enzymes associated with lipid metabolism were 
found to be both up-regulated and down-regulated. The down-reg-
ulation of fatty acid elongase could be interpreted as an attempt to 
decrease anabolic processes to save energy. Also the mRNA levels
of two actin isoforms decreased signiﬁ  cantly as well as the expres-
sion of the diaphanous protein, a protein interacting with actin and 
proﬁlin (Ganguly and Lohia, 2000).
Taken together, within the limited scope of our microarray, the 
response of the amoebae shows an attempt to up-regulate some 
factors needed for the response to oxidative stress which would 
be the most speciﬁc answer to metronidazole. Above that there 
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Fig. 1. Details from Coomassie-stained 2DE-gels displaying the soluble proteome of E. histolytica trophozoites exposed to 50?M metronidazole. Upper three rows, cells 
treated with metronidazole (Mtz) for 1h, 3 h, or 5h; bottom row, control cells. The cutouts show thioredoxin, superoxide dismutase, thioredoxin reductase, actin and Hsp70 
that had been identiﬁed before (Leitsch et al., 2005, 2007). In the gels from metronidazole-treated cells the cutouts annotated as thioredoxin, superoxide dismutase, and 
thioredoxin reductase (arrows) display weaker additional spots seen at the right (basic) side of the original spots. These are portions of the protein that have been chemically 
modiﬁed by activated metronidazole (Leitsch et al., 2007).
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was a picture of a cell with a catabolic rather than anabolic state, a 
possible shift to intracellular protein degradation, to less chaperone
activity, and a feeble attempt to up-regulate energy generation.
In the whole picture, an additional feature was noted. All the 
expression changes were manifested as early as after 1 h, in most 
cases, in the hours to follow, the up-regulation or down-regula-
tion did not continue or even accelerate, but tapered off. The whole 
picture is of a cell which, though looking intact has already lost 
most of its metabolic strength.
This conclusion ﬁnally agrees well with the results from the 
comparison of the soluble proteomes of metronidazole-treated 
and untreated amoebae. It appears as if the cells are able to adapt 
their mRNA levels to a certain extent but are unable to translate 
these changes into the generation of the desired proteins. This may 
well be a consequence of the attack of activated metronidazole on 
the thiol-based redox system of the amoebae (Leitsch et al., 2007).
Nevertheless, a lot needs to be learned about the exact targets and 
chain of events leading to the death of the amoebae, before we fully 
understand this classical example of successful chemotherapy.
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4 Conclusions 
 
 
4.1 Genome annotation 
Work on this thesis project was mainly devided in two parts. The first was a large 
computational part while setting up our annotation databases. These subgenomic 
databases of enzymes, cytoskeleton genes and stress genes found in the E. histolytica 
genome provided not only a good basis for the second part of the project, the actual 
microarray work, but also had the additional benefit of giving us insights into some 
interesting traits of the E. histolytica genome, like incomplete metabolic pathways 
(Hofer and Duchêne, 2005). 
Living in the human gut gives E. histolytica easy access to host-derived organic 
compounds. Therefore many biosynthetic pathways for production of these compounds 
were secondarily lost, a typical trait of parasites (Clark et al., 2007). For instance, E. 
histolytica is not able to produce purines, pyrimidines or fatty acids de novo, but there 
are genes for putative fatty acid elongases which might extend existing fatty acids. 
During our database compilation we found eight very good homologous sequences to 
an Arabidopsis thaliana fatty acid elongase, a search with a Jojoba sequence also gave 
a good hit, all of them sharing some 50% protein sequence identiy. So amoebae can 
alter preformed compounds taken up from the host for their specific metabolic needs. 
Cholesterol is also taken up from the host (Das et al., 2002). E. histolytica is not 
able to synthesize this important part of its membrane de novo. But we found several 
enzymes for isoprenlylation present in the genome, like protein farnesyl transferase or 
geranylgeranyl transferase. These enzymes were found to be active in the 
isoprenylation of small Ras GTPases, important molecular switches of signal 
transduction in cell proliferation and differentiation (Makioka et al., 2006; Kumagai et al., 
2004). Most metabolic pathways for amino acid synthesis cannot be found, with the 
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exception of serine and cysteine (Loftus et al., 2005). Cysteine is the major intracellular 
thiol, and probably it is balancing the lack of glutathione as an important component of 
oxidative stress resistance (Fahey et al., 1984). 
During our project we found a large number of amoeba genes that could be of 
bacterial origin. After compiling the first part of our database mainly containing 
metabolic enzymes we had 112 out of 772 entries that matched nearer with bacterial 
than with eukaryotic sequences. Our findings were confirmed by the stringent 
investigation of genes of possible bacterial origin in the genome paper (Loftus et al., 
2005).  In a strict phylogenetic screen 96 genes were found where lateral gene transfer 
(LGT) is the best explanation for their presence in E. histolytica. In the more recent and 
even stricter reassessment of these data (Clark et al., 2007) only 41 cases of LGT 
remained strongly supported. This is due to the fact that between the two publications 
the sampling of prokaryotic as well as eukaryotic genomes has increased, giving partly 
divergent results for phylogenetic analyses. But still the often sparse availabilty of 
genome data (pro- and eukaryotic) inflicts a strong bias in these data, so that in the 
future more changes could be seen. Nevertheless, the importance of LGT for 
Entamoeba metabolism remains. 
These few samples show the usefulness of our databases for different 
applications, and we were happy to provide our annotations to the genome project 
consortium. For the whole genome project of course automated annotation with several 
adapted programs was done, but still a manual curation is necessary to clear 
ambiguous assignments and to improve the quality of the annotation. Our annotation 
databases were also the foundation for our part in the review of the E. histolytica 
genome structure and content (Clark et al., 2007), for which we provided a large part of 
the metabolism section.   
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4.2 E. histolytica reactions to metronidazole treatment 
 The second main part of this thesis project was the construction of a focussed 
microarray and its use for detecting the effects of metronidazole treatment on gene 
expression of amoeba. We compiled a final set of 213 genes for our array including 
glycolytic enzymes, various pathogenicity factors, all genes known to be involved in 
response to oxidative stress or heat shock as well as a number of cytoskeleton genes 
that were thought to be used as reference house keeping genes. As discussed in our 
microarray paper (Tazreiter et al., 2008) the observed changes in gene expression of E. 
histolytica under metronidazole treatment were unexpectedly few and with only small 
fold changes. One could argue that amoebae are only able to make a weak attempt of 
reacting to the drug because their standard enzymatic equipment is not capable of an 
effective defense. Metronidazole acts too quickly and negatively as to enable the cells 
to mount a coordinated defense. Other microaerophilic protist parasites with slightly 
divergent enzymatic configuration have better ways to react to the drug. For instance, 
Trichomonas vaginalis possesses a lactate dehydrogenase and is able to use it to get 
rid of excess reduction equivalents, therefore perhaps being less vulnerable to 
metronidazole. Consequently, resistance is a much graver problem in T. vaginalis 
treatment than in E. histolytica.  Furthermore, trichomonads can downregulate 
thioredoxin reductase activity (Leitsch et al., 2009), thereby also minimizing the 
activation of metronidazole to its toxic nitroradical anions. As shown for both E. 
histolytica and T. vaginalis, thioredoxin and thioredoxin reductase are located in spatial 
proximity to metronidazole, enabling thioredoxin reductase to activate metronidazole, 
but on the other hand rendering themselves vulnerable to adduct formation with 
metronidazole (Leitsch et al., 2007). Analysis of the proteome of E. histolytica with 2DE 
gels showed that no significant up- or downregulation of proteins was found, thereby 
confirming the results of the limited scope of our microarray on a broader proteomic 
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basis. So it is possible to speculate that even if we had used a whole genome 
microarray, the extent of up- or downregulated genes found because of metronidazole 
treatment might not have been very high. Five enzymes in E. histolytica were found to 
be prone to adduct formation with metronidazole, namely the already mentioned 
thioredoxin and thioredoxin reductase, superoxide dismutase, purine nucleoside 
phosphorylase and a former hypothetical protein now designated metronidazole target 
protein 1 (Mtp1) (Leitsch et al., 2007).  
The whole picture shows a cell that is not able to react properly to the 
chemotherapeutical stress. The small changes in transcriptional levels of a few genes 
cannot be translated to the upregulation of proteins. Fortunately for us, metronidazole is 
a very effective drug that E. histolytica finds only few possibilities to overcome.  
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5 Summary  
The objective of this PhD thesis was to investigate the reaction of the 
microaerophilic protist parasite Entamoeba histolytica to the standard 
chemotherapeutical agent metronidazole on the gene expression level with the help of 
oligonucleotide microarrays. On the basis of early data from the E. histolytica genome 
project we first compiled three annotation databases currently containing genes 
encoding enzymes (1334 entries), cytoskeleton proteins (222 entries), and stress genes 
and redox factors (117 entries). We found a number of genes with an assumed 
bacterial origin and established an overview about metabolic pathways present in the E. 
histolytica genome.  
In a second step we used our databases for the construction of oligonucleotide 
probes for our microarray. To investigate the reaction of amoebae to metronidazole we 
used cells of E. histolytica HM-1:IMSS treated with 50µM of metronidazole for 1 h, 3 h 
and 5 h, respectively, and untreated control cells. Fluorescently labeled cDNAs from 
these cells were hybridized to our focussed array representing 213 genes, and the data 
were analysed. 
The transcriptional response of E. histolytica to metronidazole treatment was 
unexpectedly modest, with 15 genes at least partly upregulated. Only seven showed at 
least one value with a statistically significant fold change ≥2. These were superoxide 
dismutase (SOD), peroxiredoxin, two ferredoxin genes, the Gal/GalNAc specific lectin 
light and heavy chains and a long chain fatty acid CoA ligase. Modest down-regulation 
was found with eight genes, with six genes showing at least one time point with 
significant downregulation ≤ 0.5. These were genes encoding an actin isoform, the 101 
kDa heat shock protein, a short chain dehydrogenase, a fatty acid elongase, 
diaphanous protein and a WD repeat protein. We used quantitative real time RT-PCR to 
 
- 34 -
verify these transcriptional changes for seven selected genes, and these results 
confirmed our microarray data.  
In a parallel PhD thesis the changes in protein levels were monitored with the 
help of 2DE gels. There again no significant up- or down-regulation of protein levels 
was found under metronidazole influence, but a modification of five distinct proteins by 
reduced metronidazole metabolites (Leitsch et al., 2007).  
Taken together, the response of E. histolytica to metronidazole treatment on the 
mRNA level was rather modest, with only a few genes up- or down-regulated 
significantly. Several of these upregulated genes (SOD, peroxiredoxin, thioredoxin and 
thioredoxin reductase) protect the amoeba cells against oxidative stress that is 
generated by reduced metronidazole. But on the whole, E. histolytica appears to be 
unable to mount a strong specific response to inactivate metronidazole, or to prevent its 
activation.  
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6 Zusammenfassung  
 Das Ziel dieser Dissertation war die Untersuchung der Reaktion des 
mikroaerophilen einzelligen Parasiten Entamoeba histolytica auf die Behandlung mit 
dem klassischen Chemotherapeutikum Metronidazol auf mRNA-Ebene mithilfe von 
Oligonucleotid-Microarrays. Basierend auf dem E. histolytica – Genomprojekt erstellten 
wir zuerst drei Datenbanken, die die Annotation von aktuell 1334 Enzymen, 222 
Zytoskelettgenen sowie 117 Stressgenen und Redox-Faktoren beinhalten. Wir fanden 
viele Gene, die möglicherweise bakteriellen Ursprungs sind, und etablierten einen 
Überblick über die in E. histolytica vorhandenen Stoffwechselwege.  
 In einem zweiten Schritt verwendeten wir unsere Datenbanken für das Design 
von  Oligonucleotid-Proben für unseren Microarray. Um die Reaktion von Amöben auf 
Metronidazol zu untersuchen, verwendeten wir Zellen von E. histolytica HM-1:IMSS, die 
für 1 h, 3 h oder 5 h mit jeweils 50µM Metronidazol behandelt wurden, sowie Kontroll-
Zellen. Die fluoreszenzmarkierte cDNA dieser Proben wurde auf unseren fokussierten, 
213 Gene representierenden Microarray hybridisiert und die Daten wurden 
ausgewertet. 
 Erstaunlicherweise änderte sich die Menge der transkribierten mRNAs von E. 
histolytica durch die Metronidazol-Behandlung nur sehr geringfügig. Bei 15 Genen kam 
es zu einer zumindest teilweisen Erhöhung der Transkriptionsrate, nur sieben davon 
wiesen zumindest einen Wert mit einer signifikanten Erhöhung ≥2 auf. Dies waren 
Superoxiddismutase (SOD), Peroxiredoxin, zwei Ferredoxin-Gene, leichte- und 
schwere Ketten des Gal/GalNAc-spezifischen Lektins, sowie eine Fettsäure-CoA-
Ligase mit Spezifität für lange Ketten. Bei acht Genen wurde ein leichtes 
Herunterfahren der Transkription gefunden, wobei der Wert bei sechs Genen signifikant 
auf ≤0,5 fiel. Dies waren ein Actin, das 101 kDa Hitzeschockprotein, eine kurzkettige 
Dehydrogenase, eine Fettsäure-Elongase, das sogenannte "diaphanous"-Protein sowie 
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ein "WD-repeat"-Protein. Zur Überprüfung unserer Ergebnisse führten wir für sieben 
Gene auch quantitative "real time RT-PCR" durch, welche die Microarray-Daten 
bestätigte.  
 In einer parallel laufenden Dissertation wurden die Veränderungen auf Protein-
Ebene mithilfe von zweidimensionalen Gelen untersucht. Auch hier konnte bei keinem 
Protein eine signifikante Änderung der produzierten Menge aufgrund von Metronidazol-
Einfluss gefunden werden. Alledings kam es zu Modifikationen bei fünf bestimmten 
Proteinen aufgrund der Anlagerung von reduzierten Metronidazol-Metaboliten (Leitsch 
et al., 2007).  
 Zusammenfassend gesehen reagierten E. histolytica-Zellen auf die Einwirkung 
von Metronidazol nur mit einer sehr geringen Anpassung der Transkription, nur wenige 
Gene wurden signifikant hinauf- oder hinunterreguliert. Einige dieser hochregulierten 
Gene (SOD, Peroxiredoxin, Thioredoxin und Thioredoxinreduktase) schützen die 
Amöbenzellen gegen oxidativen Stress, der von reduziertem Metronidazol verursacht 
wird. Das Gesamtbild zeigt Amöbenzellen, die zu keiner konzertierten sinnvollen 
Reaktion gegen Metronidazol imstande sind und auch die Aktivierung des 
Metronidazols nicht verhindern können.  
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8 List of abbreviations  
 
 
2D-DIGE  two-dimensional difference gel electrophoresis 
2DE   two-dimensional gel electrophoresis 
ALA    amoebic liver abscess 
Alkyl-PC  alkylphosphocholine 
Cy3/5   green (3) or red (5) fluorescent dye of the cyanine dye familiy 
ELISA   enzyme-linked immunosorbent assay 
ER    endoplasmatic reticulum 
FD    ferredoxin 
GA    Golgi apparatus 
Gal/GalNAc lectin galactose/N-acetylgalactosamine specific lectin  
Hsp10  10 kDa heat shock protein 
Hsp70  70 kDa heat shock protein   
LGT    lateral gene transfer 
LINE    long interspersed element 
LPG   lipophosphoglycan 
Mbp    mega base pairs 
PCR   polymerase chain reaction 
PFOR   pyruvate:ferredoxin oxidoreductase 
qRT-PCR quantitative real-time reverse transcription polymerase chain 
reaction 
SINE   short interspersed element 
SOD    superoxide dismutase 
TCA    trichloroacetic acid 
TSA   trichostatin A
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